Research Explorer

Your browser does not support JavaScript or JavaScript is not enabled. Without JavaScript some functions of this webapplication may be disabled or cause error messages. To enable JavaScript, please consult the manual of your browser or contact your system administrator.

Researcher

Piet Ost

Awards & Distinctions

331 Results

2024

Adjuvant EBRT for muscle-invasive bladder cancer : phase 2 trial secondary analysis (NCT02397434)

Flor VerghotePiet DirixCharles Van PraetCharlien BerghenBen VannesteSara JuniusNick LiefhoogheLeen NoéGert De MeerleerPiet Ost et al.

Cancer-specific dose and fractionation schedules in stereotactic body radiotherapy for oligometastatic disease : an interim analysis of the EORTC-ESTRO E2-RADIatE OligoCare study

Sebastian M. ChristFilippo AlongiUmberto RicardiMarta ScorsettiLorenzo LiviPanagiotis BalermpasYolande LievensPètra BraamBarbara Alicja Jereczek-FossaKarin Stellamans et al.

A1 Journal Article in RADIOTHERAPY AND ONCOLOGY

Docetaxel provides oncological benefits in the era of new-generation androgen receptor inhibitors : or is three a crowd?

Noelia SanmamedJuan Gomez-RivasDavid BuchserMiguel MontijanoMaria Antonia Gomez-AparicioVictor Duque-SantanaLisselott TorresThomas ZilliPiet OstAntonio Maldonado et al.

A1 Journal Article in CLINICAL GENITOURINARY CANCER

From mutations to splice variants : identifying liquid biopsy derived biomarkers in metastatic prostate cancer

Jan VanwelkenhuyzenPiet OstBram De LaereKatleen De Preter

Health-related quality of life in men with oligometastatic prostate cancer following metastases-directed stereotactic body radiotherapy : real-world data from the E2-RADIatE OligoCare cohort

Renée BultijnckMieke Van HemelrijckValerie FonteyneLorenzo LiviBarbara Alicja Jereczek-FossaHossein HemmatazadMichael MayingerHeike PeulenLuc VerbekeSara Ramella et al.

A1 Journal Article in CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY

Moderate hypofractionated radiotherapy for prostate cancer : 3-year toxicity results of a multicentre randomized phase 3, non-inferiority trial

Valerie FonteyneC BerghenCharles Van PraetBarbara VanderstraetenSofie VerbekeGeert VilleirsRoos ColmanBen VannestePiet OstG De Meerleer et al.

A1 Journal Article in RADIOTHERAPY AND ONCOLOGY

Multiregion sampling of de novo metastatic prostate cancer reveals complex polyclonality and augments clinical genotyping

Evan W. WarnerKim Van der EeckenAndrew J. MurthaEdmond M. KwanCameron HerbertsJoonatan SipolaSarah W. S. NgXinyi E. ChenNicolette M. FonsecaElie Ritch et al.

A1 Journal Article in NATURE CANCER

PEACE V—Salvage Treatment of OligoRecurrent nodal prostate cancer Metastases (STORM) : acute toxicity of a randomized phase 2 trial

Piet OstShankar SivaSigmund BrabrandPiet DirixNick LiefhoogheFrançois-Xavier OtteAlfonso Gomez-IturriagaWouter EveraertsMohamed ShelanAntonio Conde-Moreno et al.

A1 Journal Article in EUROPEAN UROLOGY ONCOLOGY

Stereotactic body and conventional radiotherapy for painful bone metastases : a systematic review and meta-analysis

Bas J. J. BindelsCarole MercierRoxanne GalJorrit-Jan VerlaanJoost J. C. VerhoeffPiet DirixPiet OstNicolien KaspertsYvette M. van der LindenHelena M. Verkooijen et al.

A1 Journal Article in JAMA NETWORK OPEN

TP53 structure-function relationships in metastatic castrate-sensitive prostate cancer and the impact of APR-246 treatment

Tung HoangPhilip SuteraTriet NguyenJinhee ChangShreya JagtapYang SongAmol C. ShettyDipanwita D. ChowdhuryAaron ChanFrancesca A. Carrieri et al.

A1 Journal Article in PROSTATE

The efficacy and safety of metastasis-directed therapy in patients with prostate cancer : a systematic review and meta-analysis of prospective studies

Marcin MiszczykPawel RajwaTakafumi YanagisawaZuzanna NowickaSung Ryul ShimEkaterina LaukhtinaTatsushi KawadaMarkus von DeimlingBenjamin PradereJuan Gomez Rivas et al.

A1 Journal Article in EUROPEAN UROLOGY

2023

A phase 2 randomized open-label study of oral darolutamide monotherapy vs. androgen deprivation therapy in men with hormone-naive prostate cancer (EORTC-GUCG 1532)

Bertrand F. TombalFrancisco Gomez-VeigaAlvaro Gomez-FerrerFernando Lopez-CamposPiet OstThierry Andre RoumeguereBernardo Herrera-ImbrodaLionel A. D'HondtMagali QuivrinPaolo Gontero et al.

AR and PI3K genomic profiling of cell-free DNA can identify poor responders to Lutetium-177-PSMA among patients with metastatic castration-resistant prostate cancer

Jan VanwelkenhuyzenEva Van BosSiska Van BruwaeneKarl LesageAlex MaesSezgin ÜstmertFilip LaventLaurence BeelsHenrik GrönbergPiet Ost et al.

A1 Journal Article in EUROPEAN UROLOGY OPEN SCIENCE

Accuracy and reliability of a commercial treatment planning system in nontarget regions in modern prostate radiotherapy

Willeke DanckaertPiet OstCarlos De Wagter

A1 Journal Article in JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS

Characterizing prostate cancer risk through multi-ancestry genome-wide discovery of 187 novel risk variants

Anqi WangJiayi ShenAlex A. RodriguezEdward J. SaundersFei ChenRohini JanivaraBurcu F. DarstXin ShengYili XuAlisha J. Chou et al.

A1 Journal Article in NATURE GENETICS

Checkpoint inhibitors in combination with stereotactic body radiotherapy in patients with advanced solid tumors : the CHEERS phase 2 randomized clinical trial

Mathieu SpaasNora SundahlVibeke KruseSylvie RotteyDaan De MaeseneerFréderic DuprezYolande LievensVeerle SurmontLieve BrochezDries Reynders et al.

A1 Journal Article in JAMA ONCOLOGY

Clinical and genomic differences between advanced molecular imaging-detected and conventional imaging-detected metachronous oligometastatic castration-sensitive prostate cancer

Philip SuteraYang SongKim Van der EeckenAmol C ShettyKeara EnglishTheresa HodgesJinhee ChangValerie FonteyneZaker RanaLei Ren et al.

A1 Journal Article in EUROPEAN UROLOGY

Cohort analysis to identify metastatic prostate cancer drivers

Louise de Schaetzen van BrienenKathleen MarchalPiet Ost

Defining the role of real-world data in cancer clinical research : the position of the European Organisation for Research and Treatment of Cancer

Robbe SaesenMieke Van HemelrijckJan BogaertsChristopher M. BoothJan J. CornelissenAndre DekkerElizabeth A. EisenhauerAndre FreitasAlessandro GronchiMiguel A. Hernan et al.

A1 Journal Article in EUROPEAN JOURNAL OF CANCER

Definition and diagnosis of oligometastatic bladder cancer : a Delphi consensus study endorsed by the European Association of Urology, European Society for Radiotherapy and Oncology, and European Society of Medical Oncology Genitourinary Faculty

Aristotelis BamiasArnulf StenzlStephanie L. BrownLaurence AlbigesMarko BabjukAlison BirtleAlberto BrigantiMaximilian BurgerAnanya ChoudhuryMaurizio Colecchia et al.

A1 Journal Article in EUROPEAN UROLOGY

Detection of biomarkers to reduce radiation-induced toxicities and improve clinical outcomes, with emphasis on the role of unintended dose

Willeke DanckaertPiet OstCarlos De Wagter

Dosimetric and hematologic implications of prostate-only versus whole pelvic radiotherapy : results of the multicentric phase 3 PROPER study

Valerie FonteyneWilleke DanckaertPiet OstCharlien BerghenKatrien VandecasteeleBen VannesteKato RansNick LiefhoogheSteven WallaertLeen Paelinck

A1 Journal Article in TECHNOLOGY IN CANCER RESEARCH & TREATMENT

Elective nodal irradiation for oligorecurrent nodal prostate cancer : interobserver variability in the PEACE V-STORM randomized phase 2 trial

Orane LortonVerane AchardNikolaos KoutsouvelisMaud JaccardFrederik VanhoutteGiovanna DipasqualePiet OstThomas Zilli

A2 Journal Article in ADVANCES IN RADIATION ONCOLOGY

Evaluating the impact of prostate only versus pelvic radiotherapy for pathological node-positive prostate cancer : first results from the multicenter phase 3 PROPER trial

Valerie FonteyneCharles Van PraetPiet OstSiska Van BruwaeneNick LiefhoogheCharlien BerghenGert De MeerleerBen VannesteCaroline VerbaeysSofie Verbeke et al.

A1 Journal Article in EUROPEAN UROLOGY FOCUS

Experiences of men with prostate cancer participating in a clinical pathway with a supervised group-based exercise program to combat androgen deprivation-induced side effects : a qualitative focus group study

Renée BultijnckElke RammantANNELEEN RAESNathalie VandecasteeleKarel DecaesteckerValerie FonteyneNicolaas LumenPiet OstBenedicte Deforche

A1 Journal Article in SEMINARS IN ONCOLOGY NURSING

Genomic determinants of patterns of failure in metachronous oligometastatic castration-sensitive prostate cancer

Philip SuteraKim Van der EeckenAmol ShettyYang SongTheresa HodgesSofie VerbekeJo Van DorpeValerie FonteyneBram De LaereMark V. Mishra et al.

Incorporating prostate-specific membrane antigen positron emission tomography in management decisions for men with newly diagnosed or biochemically recurrent prostate cancer

Laura BukavinaAmy N. LuckenbaughMichael S. HofmanTom HopeSophia C. KamranDeclan G. MurphyKosj YamoahPiet Ost

A1 Journal Article in EUROPEAN UROLOGY

Management of patients with advanced prostate cancer : part I : intermediate-/high-risk and locally advanced disease, biochemical relapse, and side effects of hormonal treatment : report of the Advanced Prostate Cancer Consensus Conference 2022

Silke GillessenAlberto BossiIan D. DavisJohann de BonoKarim FizaziNicholas D. JamesNicolas MottetNeal ShoreEric SmallMathew Smith et al.

A1 Journal Article in EUROPEAN UROLOGY

Management of patients with advanced prostate cancer-metastatic and/or castration-resistant prostate cancer : report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022

Silke GillessenAlberto BossiIan D. DavisJohann de BonoKarim FizaziNicholas D. JamesNicolas MottetNeal ShoreEric SmallMatthew Smith et al.

A1 Journal Article in EUROPEAN JOURNAL OF CANCER

Metastases-directed SRT and systemic therapy : EORTC-ESTRO OligoCare Delphi consensus recommendations

S. KroezeM. PavicK. StellamansYolande LievensC. BecheriniM. ScorsettiF. AlongiU. RicardiB. JereczekP. Westhoff et al.

Metastases-directed stereotactic body radiotherapy in combination with targeted therapy or immunotherapy : systematic review and consensus recommendations by the EORTC–ESTRO OligoCare consortium

Stephanie G C KroezeMatea PavicKarin StellamansYolande LievensCarlotta BecheriniMarta ScorsettiFilippo AlongiUmberto RicardiBarbara Alicja Jereczek-FossaPaulien Westhoff et al.

A1 Journal Article in LANCET ONCOLOGY

Microbiome and metabolome dynamics during radiotherapy for prostate cancer

Willeke DanckaertMathieu SpaasNora SundahlAurélie De BruyckerValerie FonteyneEllen De PaepeCarlos De WagterLynn VanhaeckePiet Ost

A1 Journal Article in RADIOTHERAPY AND ONCOLOGY

Multi-institutional analysis of metastasis directed therapy with or without androgen deprivation therapy in oligometastatic castration sensitive prostate cancer

Matthew DeekPhillip SuteraYuezhou JingDavid PryorHeather DayMai Anh HuynhBridget KoontzAndrew ArmstrongEllen DebruyckerPiet Dirix et al.

Nontarget dose accuracy and reliability of a treatment planning system during prostate radiotherapy

Willeke DanckaertPiet OstCarlos De Wagter

Overcoming complex polyclonality for accurate clinical genotyping in metastatic prostate cancer

Alexander W. WyattAndrew J. MurthaEvan WarnerKim Van der EeckenEdmond M. KwanCameron HerbertsJoonatan SipolaSarah W. S. NgXinyi E. ChenNicolette M. Fonseca et al.

Review of prospective trials assessing the role of stereotactic body radiation therapy for metastasis-directed treatment in oligometastatic genitourinary cancers

Mai Anh HuynhChad TangShankar SivaAlejandro BerlinRaquibul HannanAndrew WarnerBridget KoontzGert De MeeleerDavid PalmaPiet Ost et al.

A1 Journal Article in EUROPEAN UROLOGY ONCOLOGY

Stereotactic body radiation therapy after radical prostatectomy : current status and future directions

Jennifer Le GuevelouNicolas MagneFelipe CounagoJuan Martin MagsanocMatthieu VermeilleRenaud De CrevoisierNicolas Benziane-OuaritiniPiet OstTamim NiaziStephane Supiot et al.

A1 Journal Article in WORLD JOURNAL OF UROLOGY

The MIRAGE trial : optical illusion or the future of prostate stereotactic radiotherapy?

Shankar SivaPiet OstMuhammad Ali

Editorial material

The emerging role of extracranial stereotactic ablative radiotherapy for metastatic renal cell carcinoma : a systematic review

Jennifer Le GuevelouPaul SargosShankar SivaGuillaume PloussardPiet OstSilke GillessenThomas Zilli

A1 Journal Article in EUROPEAN UROLOGY FOCUS

Transcriptomic and clinical heterogeneity of metastatic disease timing within metastatic castration-sensitive prostate cancer

P A SuteraA C ShettyA HakanssonKarlien Van der EeckenY SongY LiuJ ChangValerie FonteyneA A MendesNicolaas Lumen et al.

A1 Journal Article in ANNALS OF ONCOLOGY

Using PSMA imaging for prognostication in localized and advanced prostate cancer

Matthew J. RobertsTobias MaurerMarlon PereraMatthias EiberThomas A. HopePiet OstShankar SivaMichael S. HofmanDeclan G. MurphyLouise Emmett et al.

A1 Journal Article in NATURE REVIEWS UROLOGY

WNT pathway mutations in metachronous oligometastatic castration-sensitive prostate cancer

Philip SuteraMatthew P. DeekKim Van der EeckenAmol C. ShettyJin Hee ChangTheresa HodgesYang SongSofie VerbekeJo Van DorpeValerie Fonteyne et al.

A1 Journal Article in INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

WSI based prediction of TP53 mutations identifies aggressive disease phenotype in prostate cancer

Marija PizuricaMaarten LarmuseauKim Van der EeckenLouise de Schaetzen van BrienenFrancisco Carrillo-PerezSimon IsphordingNicolaas LumenJo Van DorpePiet OstSofie Verbeke et al.

Whole slide imaging-based prediction of TP53 mutations identifies an aggressive disease phenotype in prostate cancer

Marija PizuricaMaarten LarmuseauKim Van der EeckenLouise de Schaetzen van BrienenFrancisco Carrillo-PerezSimon IsphordingNicolaas LumenJo Van DorpePiet OstSofie Verbeke et al.

A1 Journal Article in CANCER RESEARCH

2022

18F-PSMA-11 Versus 68Ga-PSMA-11 positron emission tomography/computed tomography for staging and biochemical recurrence of prostate cancer : a prospective double-blind randomised cross-over trial

Kathia De ManNick Van LaekenVanessa SchelfhoutWolfgang P. FendlerBieke LambertKen KersemansSarah PironNicolaas LumenKarel DecaesteckerValerie Fonteyne et al.

A1 Journal Article in EUROPEAN UROLOGY

A systematic review and meta-analysis on non-metastatic castration resistant prostate cancer : the radiation oncologist's perspective

Gianluca IngrossoMarta BotteroCarlotta BecheriniSaverio CainiEmanuele AliAndrea LanciaPiet OstGiuseppe SanguinetiShankar SivaThomas Zilli et al.

A1 Journal Article in SEMINARS IN ONCOLOGY

Adherence to contouring and treatment planning requirements within a multicentric trial : results of the quality assurance of the SAKK 09/10 trial

Marcus BeckManfred SassowskySami SchaerEtienne MathierMatthias HalterDaniel R. ZwahlenTobias HoelscherWinfried ArnoldBulent PolatGuido Hildebrandt et al.

A1 Journal Article in INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Adjuvant radiotherapy after radical cystectomy for patients with high-risk muscle-invasive bladder cancer : results of a multicentric phase II trial

Valerie FonteyneP. DirixCharles Van PraetC. BerghenM. AlbersenS. JuniusN. LiefhoogheL. NoéG. De MeerleerPiet Ost et al.

A1 Journal Article in EUROPEAN UROLOGY FOCUS

Bone health and therapeutic agents in advanced prostate cancer

Maria Antonia Gómez-AparicioFernando López-CamposLira Pelari-MiciDavid BuchserJorge PastorXavier MaldonadoJuan ZafraAlison C. TreeRenée BultijnckPaul Sargos et al.

A1 Journal Article in FRONTIERS IN BIOSCIENCE-LANDMARK

Clinical trial protocol for ProBio : an outcome-adaptive and randomised multiarm biomarker-driven study in patients with metastatic prostate cancer

Bram De LaereAlessio CrippaAndrea DiscacciatiBerit LarssonJan OldenburgAshkan MortezaviPiet OstMartin EklundJohan LindbergHenrik Gronberg et al.

Editorial material

Detection and treatment of oligorecurrent prostate cancer : the next step towards cure

Aurélie De BruyckerPiet OstValerie Fonteyne

Genomic biomarkers to guide precision radiotherapy in prostate cancer

Philip SuteraMatthew P. DeekKim Van der EeckenAlexander W. WyattAmar U. KishanJason K. MolitorisMatthew J. FerrisM. Minhaj SiddiquiZaker RanaMark V. Mishra et al.

A1 Journal Article in PROSTATE

Genomic features of lung-recurrent hormone-sensitive prostate cancer

Nicolette M. FonsecaKim Van der EeckenCameron HerbertsSofie VerbekeSarah W.S. NgNicolaas LumenElie RitchAndrew J. MurthaCecily Q. BernalesElena Schönlau et al.

A1 Journal Article in JCO PRECISION ONCOLOGY

Genomic features of lung-recurrent hormone-senstive prostate cancer

Nicolette M. FonsecaKim Van der EeckenCameron HerbertsSofie VerbekeSarah W. S. NgNicolaas LumenElie RitchAndrew J. MurthaCecily Q. BernalesElena Schonlau et al.

A1 Journal Article in JCO PRECISION ONCOLOGY

Health related quality of life outcomes following stereotactic body radiotherapy in patients with oligo-metastatic disease : a systematic review and individual patient data meta-analysis

Aisling S. BarryJoelle HelouAndrea BezjakRebecca WongLaura A. DawsonJolie RingashRouhi FazelzadZhihui LiuRobert OlsonDavid Palma et al.

A1 Journal Article in RADIOTHERAPY AND ONCOLOGY

Impact of 18F-PSMA-11 PET/CT on management of biochemical recurrence and high-risk prostate cancer staging 18F-PSMA-11 PET/CT and impact on prostate cancer management

Kathia De ManSarah PironNick Van LaekenLOUKE DELRUEValerie FonteyneNicolaas LumenBLIEDE VAN DEN BROECKKen KersemansPiet OstVanessa Schelfhout

A1 Journal Article in MOLECULAR IMAGING AND BIOLOGY

Impact of radiotherapy parameters on the risk of lymphopenia in urological tumors : a systematic review of the literature

Willeke DanckaertMathieu SpaasKatrien VandecasteeleCarlos De WagterPiet Ost

A1 Journal Article in RADIOTHERAPY AND ONCOLOGY

Lack of consensus identifies important areas for future clinical research : Advanced Prostate Cancer Consensus Conference (APCCC) 2019 findings

Ursula M. VoglTomasz M. BeerIan D. DavisNeal D. ShoreChristopher J. SweeneyPiet OstGerhardt AttardAlberto BossiJohann de BonoCharles G. Drake et al.

A1 Journal Article in EUROPEAN JOURNAL OF CANCER

Long-term outcomes and genetic predictors of response to metastasis-directed therapy versus observation in oligometastatic prostate cancer : analysis of STOMP and ORIOLE trials

MP DeekK Van der EeckenP SuteraRA DeekValerie FonteyneAA MendesKarel DecaesteckerAP KiessNicolaas LumenR Phillips et al.

A1 Journal Article in JOURNAL OF CLINICAL ONCOLOGY

Management of patients with advanced prostate cancer : report from the Advanced Prostate Cancer Consensus Conference 2021

Silke GillessenAndrew ArmstrongGert AttardTomasz M. BeerHimisha BeltranAnders BjartellAlberto BossiAlberto BrigantiRobert G. BristowMuhammad Bulbul et al.

A1 Journal Article in EUROPEAN UROLOGY

Multi-focal genomic dissection of synchronous primary and metastatic tissue from de novo metastatic prostate cancer

A. J. MurthaE. WarnerKim Van der EeckenE. KwanC. HerbertsJ. SipolaS. NgE. ChenN. FonsecaE. Schonlau et al.

Multicentric prospective local treatment of metastatic prostate cancer (LoMP) study

Sarah BuelensFilip PoelaertTom ClaeysElise De BleserBert DhondtWesley VerlaPiet OstBernard RappeBart De TroyerCaroline Verbaeys et al.

A1 Journal Article in BJU INTERNATIONAL

Oligorecurrent nodal prostate cancer : radiotherapy quality assurance of the randomized PEACE V-STORM phase II trial

Verane AchardMaud JaccardFrederik VanhoutteShankar SivaReino HeikkilaPiet DirixNick LiefhoogheFrancois-Xavier OtteAlfonso Gomez-IturriagaCharlien Berghen et al.

A1 Journal Article in RADIOTHERAPY AND ONCOLOGY

Optimizing rehabilitation interventions in men with prostate cancer receiving androgen deprivation therapy

Renée BultijnckPiet OstBenedicte Deforche

PEACE V - STORM randomized phase II trial for oligorecurrent nodal prostate cancer : acute toxicity

T. ZilliS. SivaR. HeikkilaP. DirixN. LiefhoogheF. OtteA. Gomez-IturriagaW. EveraertsM. ShelanA. Conde-Moreno et al.

Prostate cancer risk stratification improvement across multiple ancestries with new polygenic hazard score

[missing] Minh-Phuong Huynh-LeRoshan KarunamuniChun Chieh FanLui AsonaWesley K. ThompsonMaria Elena MartinezRosalind A. EelesZsofia Kote-JaraiKenneth R. MuirArtitaya Lophatananon et al.

A1 Journal Article in PROSTATE CANCER AND PROSTATIC DISEASES

Recommendations for radiation therapy in oligometastatic prostate cancer : an ESTRO-ACROP Delphi consensus

Thomas ZilliVerane AchardAlan Dal PraNina Schmidt-HegemannBarbara Alicja Jereczek-FossaAndrea LanciaGianluca IngrossoFilippo AlongiShafak AluwiniStefano Arcangeli et al.

A1 Journal Article in RADIOTHERAPY AND ONCOLOGY

Stereotactic ablative radiotherapy as a tool in renal cell carcinoma for building RAPPORT with systemic therapy

Carole MercierMichiel StrijbosPiet Ost

Editorial material

Stereotactic body radiation therapy for oligometastasis : GUst Do It?

Rachel M. GlicksmanDavid A. PalmaMatthew P. DeekC. Jillian TsaiSteve ChmuraShankar SivaPiet OstPhuoc T. TranAlejandro Berlin

A1 Journal Article in INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Toward methodology for comprehensive androgen receptor splice variant profiling in cell-free RNA from patients with metastatic prostate cancer

Jan VanwelkenhuyzenPieter-Jan van DamKatleen De PreterJohan LindbergPiet OstBram De Laere

Towards the discovery of prognostic and predictive biomarkers in CHEERS, a radioimmunotherapy phase II trial

Jan VanwelkenhuyzenMathieu SpaasKim Van der EeckenVibeke KruseSylvie RotteyLieve BrochezJohan LindbergKatleen De PreterBram De LaerePiet Ost

Unraveling the genomic underpinnings of advanced prostate cancer

Kim Van der EeckenPiet OstJo Van DorpeSofie Verbeke

What experts think about prostate cancer management during the COVID-19 pandemic : report from the Advanced Prostate Cancer Consensus Conference 2021

Fabio TurcoAndrew ArmstrongGerhardt AttardTomasz M. BeerHimisha BeltranAnders BjartellAlberto BossiAlberto BrigantiRob G. BristowMuhammad Bulbul et al.

A1 Journal Article in EUROPEAN UROLOGY

2021

Adjuvant radiotherapy after radical cystectomy for patients with muscle invasive bladder cancer : results of a phase 2 trial

Flor VerghoteP. DirixCharles Van PraetC. BerghenM. AlbersenS. JuniusN. LiefhoogheM. BrosensG. De MeerleerPiet Ost et al.

Adoption of single fraction radiotherapy for uncomplicated bone metastases in a tertiary centre

Cedric PetersJulie VandewieleYolande LievensMarc Van EijkerenValerie FonteyneTom BoterbergPieter DeseyneLiv VeldemanWilfried De NeveChristel Monten et al.

A1 Journal Article in CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY

Checkpoint inhibition in combination with an immunoboost of external beam radiotherapy in solid tumors (CHEERS) : study protocol for a phase 2, open-label, randomized controlled trial

Mathieu SpaasNora SundahlEva HulstaertVibeke KruseSylvie RotteyDaan De MaeseneerVeerle SurmontAnnabel MeiresonLieve BrochezDries Reynders et al.

A1 Journal Article in BMC CANCER

Clinical and genomic indolence in lung-recurrent metastatic hormone-sensitive prostate cancer

Nicolette FonsecaKim Van der EeckenCameron HerbertsSofie VerbekeSarah NgNicolaas LumenElie RitchAndrew MurthaCecily BernalesElena Schönlau et al.

Clinical relevance of serum Kyn/Trp ratio and basal and IFN gamma-upregulated IDO1 expression in peripheral monocytes in early stage melanoma

Annabel MeiresonLiesbeth FerdinandeMarc HaspeslaghBenjamin HennartDelphine AllorgePiet OstNora SundahlMathieu SpaasAnnelies DemeyerLieve Brochez

A1 Journal Article in FRONTIERS IN IMMUNOLOGY

Combined longitudinal clinical and autopsy phenomic assessment in lethal metastatic prostate cancer : recommendations for advancing precision medicine

Juho JasuTeemu TolonenEmmanuel S. AntonarakisHimisha BeltranSusan HalabiMario A. EisenbergerMichael A. CarducciYohann LoriotKim Van der EeckenMartijn Lolkema et al.

A1 Journal Article in EUROPEAN UROLOGY OPEN SCIENCE

Development of a method for generating SNP interaction-aware polygenic risk scores for radiotherapy toxicity

Nicola Rares FrancoMichela Carlotta MassiFrancesca IevaAndrea ManzoniAnna Maria PaganoniPaolo ZuninoLiv VeldemanPiet OstValerie FonteyneChristopher J. Talbot et al.

A1 Journal Article in RADIOTHERAPY AND ONCOLOGY

Emerging prognostic groups across the spectrum of metastatic castration-sensitive prostate cancer : disease outcomes and genomics

P. SuteraKim Van der EeckenA.U. KishanA. HamidE. GristG. AttardT.L. LotanA. MendesC. SweeneyC. Paller et al.

Evaluating the impact of 18F-FDG-PET-CT on risk stratification and treatment adaptation for patients with muscle-invasive bladder cancer (EFFORT-MIBC) : a phase II prospective trial

Flor VerghoteLindsay PoppeSofie VerbekePiet DirixMaarten AlbersenGert De MeerleerCharlien BerghenPiet OstGeert VilleirsPieter De Visschere et al.

A1 Journal Article in BMC CANCER

Exercise prescription dose for castrate-resistant prostate cancer patients : a phase I prescription dose escalation trial

Renée BultijnckBenedicte DeforcheNoëmi BorreyJörgen Van BauwelMaarten LievensElke RammantValerie FonteyneKarel DecaesteckerAdelheid SteyaertNicolaas Lumen et al.

A1 Journal Article in WORLD JOURNAL OF UROLOGY

Genetic testing in prostate cancer in clinical practice

Robin de PutterBram De LaerePiet OstKathleen Claes

A2 Journal Article in BELGIAN JOURNAL OF MEDICAL ONCOLOGY

Genomic features of lung-recurrent hormone sensitive prostate cancer

Kim Van der EeckenNicolette FonsecaCameron HerbertsSofie VerbekeSarah NgNicolaas LumenElie RitchAndrew MurthaCecily BernalesElena Schönlau et al.

Health-related quality of life in patients with advanced prostate cancer : a systematic review

Alexander KretschmerGuillaume PloussardIsabel HeideggerIgor TsaurHendrik BorgmannCristian SurcelRomain MathieuPieter De VisschereMassimo ValerioRoderick C.N. van den Bergh et al.

A1 Journal Article in EUROPEAN UROLOGY FOCUS

Immune monitoring in melanoma and urothelial cancer patients treated with anti-PD-1 immunotherapy and SBRT discloses tumor specific immune signatures

Annabel MeiresonSimon TavernierSofie Van GassenNora SundahlAnnelies DemeyerMathieu SpaasVibeke KruseLiesbeth FerdinandeJo Van DorpeBenjamin Hennart et al.

A1 Journal Article in CANCERS

Immuno-radiotherapy in solid tumors : preliminary results of the randomized phase 2 CHEERS trial

Mathieu SpaasNora SundahlSylvie RotteyVIBEKE KRUSEDaan De MaeseneerFréderic DuprezPiet DirixVeerle SurmontYolande LievensRobin Van den Begin et al.

Increased pathway complexity is a prognostic biomarker in metastatic castration-resistant prostate cancer

Bram De LaereA CrippaA MortezaviC GhyselP RajanM EklundA WyattL DirixPiet OstH Grönberg et al.

A1 Journal Article in CANCERS

Multifocality in prostate cancer : implications for PAM50 subtyping using an index lesion-only approach

Kim Van der EeckenMaarten LarmuseauJan VanwelkenhuyzenNicolaas LumenKathleen MarchalJo Van DorpePiet OstBram De LaereSofie Verbeke

Progression-directed therapy for oligoprogression in castration-refractory prostate cancer

Charlien BerghenSteven JoniauPiet OstKenneth PoelsWouter EveraertsKarel DecaesteckerKarin HaustermansGaëtan DevosGert De Meerleer

A1 Journal Article in EUROPEAN UROLOGY ONCOLOGY

Spatiotemporal evolution of radiation myositis on 18F-FDG PET/CT following hypofractionated radiotherapy of intramuscular melanoma metastases

Mathieu SpaasBliede Van den BroeckDavid CreytensVibeke KrusePiet Ost

Editorial material

The multicenter, randomized, phase 2 PEACE V-STORM trial : defining the best salvage treatment for oligorecurrent nodal prostate cancer metastases

Thomas ZilliPiet DirixReino HeikkilaNick LiefhoogheShankar SivaAlfonso Gomez-IturriagaWouter EveraertsFrancois OtteMohamed ShelanCarole Mercier et al.

Editorial material

The mutational landscape of metastatic castration-sensitive prostate cancer : the spectrum theory revisited

Matthew P. DeekKim Van der EeckenRyan PhillipsNeil R. ParikhPedro Isaacsson VelhoTamara L. LotanAmar U. KishanTobias MaurerPaul C. BoutrosChristopher Hovens et al.

A1 Journal Article in EUROPEAN UROLOGY

The role of cytoreductive radical prostatectomy in the treatment of newly diagnosed low-volume metastatic prostate cancer : results from the local treatment of metastatic prostate cancer (LoMP) registry

Nicolaas LumenElise De BleserSarah BuelensWesley VerlaFilip PoelaertWietse ClaeysValerie FonteyneSofie VerbekeGeert VilleirsKathia De Man et al.

A1 Journal Article in EUROPEAN UROLOGY OPEN SCIENCE

Tissue- and blood-derived genomic biomarkers for metastatic hormone-sensitive prostate cancer : a systematic review

Kim Van der EeckenJan VanwelkenhuyzenMatthew P. DeekPhuoc T. TranEvan WarnerAlexander W. WyattEdmond M. KwanSofie VerbekeJo Van DorpeValerie Fonteyne et al.

A1 Journal Article in EUROPEAN UROLOGY ONCOLOGY

2020

A deep learning approach validates genetic risk factors for late toxicity after prostate cancer radiotherapy in a REQUITE Multi-National Cohort

Michela Carlotta MassiFrancesca GasperoniFrancesca IevaAnna Maria PaganoniPaolo ZuninoAndrea ManzoniNicola Rares FrancoLiv VeldemanPiet OstValerie Fonteyne et al.

A1 Journal Article in FRONTIERS IN ONCOLOGY

A trial-based cost-utility analysis of metastasis-directed therapy for oligorecurrent prostate cancer

Elise De BleserRuben WillemsKarel DecaesteckerLieven AnnemansAurélie De BruyckerValerie FonteyneNicolaas LumenFilip AmeyeIgnace BillietSteven Joniau et al.

A1 Journal Article in CANCERS

Adoption of single-fraction radiotherapy for uncomplicated bone metastases in a tertiary centre

Cedric PetersJulie VandewieleYolande LievensMarc Van EijkerenValerie FonteyneTom BoterbergPieter DeseyneLiv VeldemanWilfried De NeveChristel Monten et al.

Characterisation and classification of oligometastatic disease : a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation

Matthias GuckenbergerYolande LievensAngelique B. BoumaLaurence ColletteAndre DekkerNandita M. deSouzaAnne-Marie C. DingemansBeatrice FournierCoen HurkmansFrédéric E. Lecouvet et al.

A1 Journal Article in LANCET ONCOLOGY

Comparative analysis of somatic variant calling on matched FF and FFPE WGS samples

Louise de Schaetzen van BrienenMaarten LarmuseauKim Van der EeckenFREDERIC DE RYCKPauline Robbe VandewalleAnna SchuhJan FostierPiet OstKathleen Marchal

A1 Journal Article in BMC MEDICAL GENOMICS

Effect of extended pelvic lymph node dissection on oncologic outcomes in patients with D'Amico intermediate and high risk prostate cancer treated with radical prostatectomy : a multi-institutional study

Felix PreisserRoderick C. N. van den BerghGiorgio GandagliaPiet OstChristian I. SurcelPrasanna SooriakumaranFrancesco MontorsiMarkus GraefenHenk van der PoelAlexandre de la Taille et al.

A1 Journal Article in JOURNAL OF UROLOGY

External validation of the 2019 Briganti nomogram for the identification of prostate cancer patients who should be considered for an extended pelvic lymph node dissection

Giorgio GandagliaAlberto MartiniGuillaume PloussardNicola FossatiArmando StabilePieter De VisschereHendrik BorgmannIsabel HeideggerFabian SteinkohlAlexander Kretschmer et al.

A1 Journal Article in EUROPEAN UROLOGY

Health-related quality of life overview after different curative treatment options in muscle-invasive bladder cancer : an umbrella review

Elke RammantLisa Van WilderMieke Van HemelrijckNele PauwelsKarel DecaesteckerCharles Van PraetRenée BultijnckPiet OstThomas Van VaerenberghSofie Verhaeghe et al.

A1 Journal Article in QUALITY OF LIFE RESEARCH

Hyperbaric oxygen therapy for radiation cystitis after pelvic radiotherapy : systematic review of the recent literature

Lauren VilleirsThomas TaillyPiet OstMarjan WaterloosKarel DecaesteckerValerie FonteyneCharles Van PraetNicolaas Lumen

A1 Journal Article in INTERNATIONAL JOURNAL OF UROLOGY

Inferring the genomic landscape of lymph-node positive high-risk prostate cancer

Jan VanwelkenhuyzenKim Van der EeckenBram De LaereSimon SundlingRebecka BergströmJohan LindbergKatleen De PreterHenrik GrönbergPiet Ost

Management of patients with advanced prostate cancer : report of the Advanced Prostate Cancer Consensus Conference 2019

Silke GillessenaGerhardt AttardTomasz M. BeerHimisha BeltranAnders BjartellAlberto BossiAlberto BrigantiRob G. BristowKim N. ChiNoel Clarke et al.

A1 Journal Article in EUROPEAN UROLOGY

Nonsurgical salvage local therapies for radiorecurrent prostate cancer : a systematic review and meta-analysis

Gianluca IngrossoCarlotta BecheriniAndrea LanciaSaverio CainiPiet OstGiulio FrancoliniMorten HoyerMarta BotteroAlberto BossiThomas Zilli et al.

A1 Journal Article in EUROPEAN UROLOGY ONCOLOGY

Optimization of PET protocol and interrater reliability of 18F-PSMA-11 imaging of prostate cancer

Sarah PironKathia De ManVanessa SchelfhoutNick Van LaekenKen KersemansEric AchtenFilip De VosPiet Ost

A1 Journal Article in EJNMMI RESEARCH

PEACE V - Salvage Treatment of OligoRecurrent nodal prostate cancer Metastases (STORM) : a study protocol for a randomized controlled phase II trial

Aurélie De BruyckerAn SpiessensP. DirixN. KoutsouvelisI. SemacN. LiefhoogheA. Gomez-IturriagaW. EveraertsF. OtteA. Papachristofilou et al.

A1 Journal Article in BMC CANCER

PET–CT for staging patients with muscle invasive bladder cancer : is it more than just a fancy tool?

Valerie FonteyneKathia De ManKarel DecaesteckerPieter De VisschereP. DirixG. De MeerleerC. BerghenPiet OstGeert Villeirs

A1 Journal Article in CLINICAL AND TRANSLATIONAL IMAGING

Phase II open-label study investigating apalutamide in patients with biochemical progression after radical prostatectomy

Piet DirixMichiel StrijbosTom Van den MooterNick LiefhoogheSiska Van BruwaenePieter UvinChristophe GhyselDieter OstPeter SchattemanSamuel Bral et al.

A1 Journal Article in FUTURE ONCOLOGY

Prostate cancer : ESMO clinical practice guidelines for diagnosis, treatment and follow-up

C. ParkerE. CastroK. FizaziA. HeidenreichPiet OstG. ProcopioB. TombalS. Gillessen

A1 Journal Article in ANNALS OF ONCOLOGY

Radiotherapy treatment volumes for oligorecurrent nodal prostate cancer : a systematic review

Verane AchardMarta BotteroMichel RouzaudAndrea LanciaMarta ScorsettiAndrea Riccardo FilippiCiro FranzeseBarbara Alicja Jereczek-FossaGianluca IngrossoPiet Ost et al.

A1 Journal Article in ACTA ONCOLOGICA

Radium-223 within the evolving treatment options for metastatic castration-resistant prostate cancer : recommendations from a European expert working group

Joe M. O'SullivanJoan CarlesRichard CathomasAlfonso Gomez-IturriagaDaniel HeinrichGero KramerPiet OstInge van OortBertrand Tombal

A1 Journal Article in EUROPEAN UROLOGY ONCOLOGY

Reply to Pirus Ghadjar, Thomas Wiegel’s letter to the editor re : Elise De Bleser, Barbara Alicja Jereczek-Fossa, David Pasquier, et al. Metastasis-directed therapy in treating nodal oligorecurrent prostate cancer : a multi-institutional analysis comparing the outcome, toxicity of stereotactic body radiotherapy, elective nodal radiotherapy. Eur Urol 2019;76:732–9

Elise De BleserPiet Ost

A1 Journal Article in EUROPEAN UROLOGY

Shifting the paradigm towards local therapies for oligometastatic prostate cancer

Elise De BleserPiet OstNicolaas Lumen

The European Organisation for Research and Treatment of Cancer, State of Science in radiation oncology and priorities for clinical trials meeting report

Gillian ThomasElizabeth EisenhauerRobert G. BristowCai GrauCoen HurkmansPiet OstMatthias GuckenbergerEric DeutschDenis LacombeDamien C. Weber

A1 Journal Article in EUROPEAN JOURNAL OF CANCER

The ProBio trial : molecular biomarkers for advancing personalized treatment decision in patients with metastatic castration-resistant prostate cancer

Alessio CrippaBram De LaereAndrea DiscacciatiBerit LarssonJason T. ConnorErin E. GabrielCamilla ThellenbergElin JanesGunilla EnbladAnders Ullen et al.

A1 Journal Article in TRIALS

Tracking the origins of metastatic seeding in de novo metastatic prostate cancer

Kim Van der EeckenEvan WarnerNicolaas LumenMatti AnnalaAndrew MurthaElena SchönlauNicolette FonsecaCameron HerbertsJan VanwelkenhuyzenWesley Verla et al.

Unravelling the proteomic landscape of extracellular vesicles in prostate cancer by density-based fractionation of urine

Bert DhondtEdward GeeurickxJoeri TulkensJan Van DeunGlenn VergauwenLien LippensIlkka MiinalainenPekka RappuJyrki HeinoPiet Ost et al.

A1 Journal Article in JOURNAL OF EXTRACELLULAR VESICLES

2019

A phase III randomized-controlled, single-blind trial to improve quality of life with stereotactic body radiotherapy for patients with painful bone metastases (ROBOMET)

Carole MercierPiet DirixPiet OstCharlotte BillietInes JoyePeter VermeulenYolande LievensDirk Verellen

A1 Journal Article in BMC CANCER

Abiraterone and spironolactone in prostate cancer : a combination to avoid

Bert DhondtSarah BuelensJeroen Van BesienMatthias BeysensElise De BleserPiet OstNicolaas Lumen

A1 Journal Article in ACTA CLINICA BELGICA

Aggressive variants of prostate cancer : are we ready to apply specific treatment right now?

Igor TsaurIsabel HeideggerAlexander KretschmerHendrik BorgmannGiorgio GandagliaAlberto BrigantiPieter De VisschereRomain MathieuMassimo ValerioRoderick van den Bergh et al.

A1 Journal Article in CANCER TREATMENT REVIEWS

Androgen receptor burden and poor response to abiraterone or enzalutamide in TP53 wild-type metastatic castration-resistant prostate cancer

Bram De LaerePrabhakar RajanHenrik GronbergLuc DirixJohan LindbergMarkus MayrhoferTom WhitingtonPieter-Jan van DamPeter Van OyenChristophe Ghysel et al.

A1 Journal Article in JAMA ONCOLOGY

Assessing the role and optimal duration of hormonal treatment in association with salvage radiation therapy after radical prostatectomy : results from a multi-institutional study

Nicola FossatiDaniele RobestiR. Jeffrey KarnesMatteo SoligoStephen A. BoorjianAlberto BossiGabriele CoraggioNadia Di MuzioCesare CozzariniBarbara Noris Chiorda et al.

A1 Journal Article in EUROPEAN UROLOGY

Boosting anticancer immunity with radiotherapy

Nora SundahlPiet OstVibeke KruseKarel Decaestecker

Castration-resistant prostate cancer-free survival in the multicentric prospective local treatment of metastatic prostate cancer (LoMP) trial

Sarah BuelensFilip PoelaertElise De BleserBert DhondtWesley VerlaPiet OstB. RappeB. De TroyerC. VerbaeysB. Kimpe et al.

Current insights in the management of high-risk prostate cancer : still more questions than answers

Valerie FonteynePiet Ost

Editorial material

Discovery and validation of a serum microRNA signature to characterize oligo- and polymetastatic prostate cancer : not ready for prime time

Bert DhondtElise De BleserTom ClaeysSarah BuelensNicolaas LumenJo VandesompeleAnneleen BeckersValerie FonteyneKim Van der EeckenAurélie De Bruycker et al.

A1 Journal Article in WORLD JOURNAL OF UROLOGY

Exploration of the urinary proteome in the search for new biomarkers for prostate cancer : a promising role for extracellular vesicles

Bert DhondtGlenn VergauwenJan Van DeunEdward GeeurickxLien LippensJoeri Tulkenslkka MiinalainenPekka RappuJyrki Heino Oulu, FinlandPiet Ost et al.

External beam radiotherapy only as an alternative for radical cystectomy in highly selected bladder cancer patients

Valérie FonteyneTom VercauterenNicolaas LumenWerner De GersemBruno SpeleersGeert VilleirsPiet OstPieter De VisschereKarel Decaestecker

A2 Journal Article in BIOMEDICAL JOURNAL OF SCIENTIFIC & TECHNICAL RESEARCH

Has the PROPHECY of AR-V7 been fulfilled?

Bram De LaerePiet OstHenrik GronbergJohan Lindberg

A1 Journal Article in JOURNAL OF CLINICAL ONCOLOGY

Hereditary prostate cancer : primetime for genetic testing?

Isabel HeideggerIgor TsaurHendrik BorgmannChristian SurcelAlexander KretschmerRomain MathieuPieter De VisschereMassimo ValerioRoderick CN van den BerghPiet Ost et al.

A1 Journal Article in CANCER TREATMENT REVIEWS

Imaging modalities in synchronous oligometastatic prostate cancer

Jurgen J FuttererCristian SurcelRoderick van den BerghHendrik BorgmannAlberto BrigantiGiorgio GandagliaAlexander KretschmerPiet OstPrasanna SooriakumaranDerya Tilki et al.

A1 Journal Article in WORLD JOURNAL OF UROLOGY

Immune checkpoint blockade for organ transplant patients with advanced cancer : how far can we go?

Pauline De BruynDirk Van GestelPiet OstVibeke KruseLieve BrochezHans Van VlierbergheArnaud DevresseVéronique del MarmolAlain Le MoineSandrine Aspeslagh

A1 Journal Article in CURRENT OPINION IN ONCOLOGY

Implementation of a lifestyle‐based clinical pathway in daily clinical practice in men undergoing androgen deprivation therapy for prostate cancer

Renée BultijnckAnniek BruggemanBARBARA VAN RUYMBEKEStefanie MortierAnneleen RaesElke RammantMartine De MuynckBenedicte DeforcheValerie FonteyneKarel Decaestecker et al.

Importance of metastatic volume in prognostic models to predict survival in newly diagnosed metastatic prostate cancer

Sarah BuelensElise De BleserBert DhondtWesley VerlaKarel DecaesteckerPiet OstValerie FonteyneKathia De ManCHLOE STANDAERTSylvie Rottey et al.

A1 Journal Article in WORLD JOURNAL OF UROLOGY

Introducing a castrate resistant prostate cancer (CRPC) model care pathway in Belgian hospitals : towards national standardization?

Tijl VermassenThierry RoumeguereYannick NeybuchLucien HoekxIrena FeleBrieuc SautoisWouter EveraertsDaan De MaeseneerFrederic LecouvetNicolaas Lumen et al.

A2 Journal Article in BELGIAN JOURNAL OF MEDICAL ONCOLOGY

Metastasectomy for visceral and skeletal oligorecurrent prostate cancer

Antonino BattagliaGaetan DevosKarel DecaesteckerManuel WittersLisa MorisThomas Van den BroeckCharlien BerghenWouter EveraertsMaarten AlbersenArman Tsaturyan et al.

A1 Journal Article in WORLD JOURNAL OF UROLOGY

Metastasis-directed stereotactic radiotherapy for oligoprogressive castration-resistant prostate cancer : a multicenter study

Luca TriggianiRosario MazzolaStefano Maria MagriniGianluca IngrossoPaolo BorghettiFabio TrippaAndrea LanciaBeatrice DettiGiulio FrancoliniFabio Matrone et al.

A1 Journal Article in WORLD JOURNAL OF UROLOGY

Metastasis-directed therapy in treating nodal oligorecurrent prostate cancer : a multi-institutional analysis comparing the outcome and toxicity of stereotactic body radiotherapy and elective nodal radiotherapy

Elise De BleserBarbara Alicja Jereczek-FossaDavid PasquierThomas ZilliNicholas Van AsAndrei FodorPiet DirixAlfonso Gomez-IturriagaFabio TrippaShankar Siva et al.

A1 Journal Article in EUROPEAN UROLOGY

Nodal oligorecurrent prostate cancer : anatomic pattern of possible treatment failure in relation to elective surgical and radiotherapy treatment templates

Aurélie De BruyckerElise De BleserKarel DecaesteckerValerie FonteyneNicolaas LumenPieter De VisschereKathia De ManLouke DelrueBieke LambertPiet Ost

A1 Journal Article in EUROPEAN UROLOGY

Oligometastatic prostate cancer : the game is afoot

Andrea LanciaThomas ZilliVerane AchardPiet DirixWouter EveraertsAlfonso Gomez-IturriagaGianluca IngrossoNick LiefhoogheRaymond MiralbellShankar Siva et al.

A1 Journal Article in CANCER TREATMENT REVIEWS

Oligorecurrent prostate cancer limited to lymph nodes : getting our ducks in a row

Andrei FodorAndrea LanciaFrancesco CeciMaria PicchioMorten HoyerBarbara Alicja Jereczek-FossaPiet OstPaolo CastellucciElena IncertiNadia Di Muzio et al.

A1 Journal Article in WORLD JOURNAL OF UROLOGY

Outcomes after a first and/or second salvage treatment in patients with oligometastatic prostate cancer recurrence detected by (18-F) choline PET-CT

Alfonso Gomez-IturriagaFrancisco Casquero OcioPiet OstIratxe FernandezEmilia RodenoRoberto LlarenaJorge Garcia-OlaverriRoberto Ortiz de ZarateJon CacicedoAlina Ahtamon et al.

A1 Journal Article in EUROPEAN JOURNAL OF CANCER CARE

Patient- versus physician-reported outcomes in prostate cancer patients receiving hypofractionated radiotherapy within a randomized controlled trial

Elke RammantPiet OstMartijn SwimbergheBarbara VanderstraetenNicolaas LumenKarel DecaesteckerRenée BultijnckGert De MeerleerCamille SarrazynRoos Colman et al.

A1 Journal Article in STRAHLENTHERAPIE UND ONKOLOGIE

Pelvic lymph node dissection in prostate cancer staging : evaluation of morbidity and oncological outcomes

Andries Van HueleFilip PoelaertValerie FonteyneKarel DecaesteckerPiet OstNicolaas Lumen

A1 Journal Article in ACTA CHIRURGICA BELGICA

Phase 2 trial of nivolumab combined with stereotactic body radiation therapy in patients with metastatic or locally advanced inoperable melanoma

Nora SundahlTeofila SeremetJo Van DorpeBart NeynsLiesbeth FerdinandeAnnabel MeiresonLieve BrochezVibeke KrusePiet Ost

A1 Journal Article in INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Positive pre-biopsy MRI : are systematic biopsies still useful in addition to targeted biopsies?

Guillaume PloussardHendrik BorgmannAlberto BrigantiPieter De VisschereJurgen J FüttererGiorgio GandagliaIsabel HeideggerAlexander KretschmerRomain MathieuPiet Ost et al.

A1 Journal Article in WORLD JOURNAL OF UROLOGY

REQUITE: A prospective multicentre cohort study of patients undergoing radiotherapy for breast, lung or prostate cancer

Petra SeiboldAdam WebbMiguel E. Aguado-BarreraDavid AzriaCeline BourgierMuriel BrenguesErik BriersRenée BultijnckPatricia Calvo-CrespoAna Carballo et al.

A1 Journal Article in Radiotherapy and Oncology

Radiation dosimetry and biodistribution of 18F-PSMA-11 for PET imaging of prostate cancer

Sarah PironKathia De ManNick Van LaekenYves D'AsselerKlaus BacherKen KersemansPiet OstKarel DecaesteckerPieter DeseyneValerie Fonteyne et al.

A1 Journal Article in JOURNAL OF NUCLEAR MEDICINE

Randomized phase 1 trial of pembrolizumab with neo-adjuvant versus concomitant stereotactic body radiotherapy in metastatic urothelial carcinoma: Clinical and translational results

Piet OstNora SundahlG VandekerkhoveKarel DecaesteckerAnnabel MeiresonPieter De VisschereValerie FonteyneDaan De MaeseneerDries ReyndersEls Goetghebeur et al.

Randomized phase 1 trial of pembrolizumab with sequential versus concomitant stereotactic body radiotherapy in metastatic urothelial carcinoma

Nora SundahlGillian VandekerkhoveKarel DecaesteckerAnnabel MeiresonPieter De VisschereValerie FonteyneDaan De MaeseneerDries ReyndersEls GoetghebeurJo Van Dorpe et al.

A1 Journal Article in EUROPEAN UROLOGY

Randomized phase I trial of pembrolizumab with neo-adjuvant versus concomitant stereotactic body radiotherapy in metastatic urothelial carcinoma : clinical and translational results

Gillian VandekerkhoveNora SundahlKarel DecaesteckerAnnabel MeiresonPieter De VisschereValerie FonteyneDaan De MaeseneerDries ReyndersEls GoetghebeurJo Van Dorpe et al.

Re: Gaetan Devos, Gert De Meerleer, Steven Joniau. Have we entered the era of imaging before salvage treatment for recurrent prostate cancer? Eur Urol 2019;76:265-7

Aurélie De BruyckerValerie FonteynePiet Ost

A1 Journal Article in EUROPEAN UROLOGY

Re: [Lu-177]-PSMA-617 radionuclide treatment in patients with metastatic castration-resistant prostate cancer (LuPSMA trial) : a single-centre, single-arm, phase 2 study

Kathia De ManPiet Ost

Editorial material

Readressing the rationale of irradiation in stage I seminoma guidelines : a critical essay

Charlien BerghenMaarten AlbersenPierre BlanchardAlberto BossiAlberto BrigantiCesare CozzariniKarel DecaesteckerValerie FonteyneKarin HaustermansSteven Joniau et al.

A1 Journal Article in BJU INTERNATIONAL

Salvage lymph node dissection for nodal recurrent prostate cancer : a systematic review

Guillaume PloussardGiorgio GandagliaHendrik BorgmannPieter De VisschereIsabel HeideggerAlexander KretschmerRomain MathieuCristian SurcelDerya TilkiIgor Tsaur et al.

A1 Journal Article in EUROPEAN UROLOGY

Standard of care versus metastases-directed therapy for PET-detected nodal oligorecurrent prostate cancer following multimodality treatment : a multi-institutional case-control study

Thomas SteuberCordula JilgPierre TennstedtAurélie De BruyckerD. TilkiKarel DecaesteckerT. ZilliBarbara Alicja Jereczek-FossaUlrich WetterauerAnca-Ligia Grosu et al.

A1 Journal Article in EUROPEAN UROLOGY FOCUS

TP53 outperforms other androgen receptor biomarkers to predict abiraterone or enzalutamide outcome in metastatic castration-resistant prostate cancer

Bram De LaereSteffi OeyenMarkus MayrhoferTom WhitingtonPieter-Jan van DamPeter Van OyenChristophe GhyselJozef AmpePiet OstWim Demey et al.

A1 Journal Article in CLINICAL CANCER RESEARCH

The case against the European Medicines Agency's change to the label for radium-223 for the treatment of metastatic castration-resistant prostate cancer

Joe M. O'SullivanDaniel HeinrichNicholas D. JamesSten NilssonPiet OstChristopher C. ParkerBertrand Tombal

A1 Journal Article in EUROPEAN UROLOGY

Trends in management of oligometastatic hormone-sensitive prostate cancer

Gargi KothariPiet OstPatrick CheungPierre BlanchardAlison C. TreeNicholas J. van AsSimon S. LoDrew MoghanakiAndrew LoblawShankar Siva

A1 Journal Article in CURRENT ONCOLOGY REPORTS

Trends in radical prostatectomy risk group distribution in a European multicenter analysis of 28 572 patients : towards tailored treatment

Roderick van den BerghGiorgio GandagliaDerya TilkiHendrik BorgmannPiet OstChristian SurcelMassimo ValerioPrasanna SooriakumaranLaurent SalomonAlberto Briganti et al.

A1 Journal Article in EUROPEAN UROLOGY FOCUS

Understanding physical activity behavior in patients with bladder cancer before and after radical cystectomy : a qualitative interview study

Elke RammantValerie FonteyneKarel DecaesteckerRenée BultijnckBenedicte DeforcheRonny PietersPiet OstSofie VerhaegheAnn Van Hecke

A1 Journal Article in CLINICAL REHABILITATION

What is oligometastatic prostate cancer?

Michael FraserBridget KoontzUrban EmmeneggerGert De MeerleerVincent KhooFelix FengNiall M. CorcoranChristopher M. HovensPhuoc T. TranPiet Ost et al.

A1 Journal Article in EUROPEAN UROLOGY FOCUS

2018

4 Weeks versus 5 weeks of hypofractionated high-dose radiation therapy as primary therapy for prostate cancer : interim safety analysis of a randomized phase 3 trial

Valerie FonteyneCamille SarrazynMartijn SwimbergheGert De MeerleerElke RammantBarbara VanderstraetenFRANK VANPACHTENBEKENicolaas LumenKarel DecaesteckerRoos Colman et al.

A1 Journal Article in INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

A systematic review of exercise and psychosocial rehabilitation interventions to improve health-related outcomes in patients with bladder cancer undergoing radical cystectomy

Elke RammantKarel DecaesteckerRenée BultijnckNora SundahlPiet OstNele PauwelsBenedicte DeforcheRonny PietersValerie Fonteyne

A1 Journal Article in CLINICAL REHABILITATION

AR-V7 predicting treatment response in metastasized prostate cancer : has it peaked?

Igor TsaurHendrik BorgmannChristian I. SurcelPiet OstGuillaume Ploussard

A1 Journal Article in WORLD JOURNAL OF UROLOGY

Are clinical guidelines designed according to guidelines? Cross-sectional assessment of quality and transparency of clinical guidelines in urology

Roderick C. N. van den BerghPiet OstChristian SurcelMassimo ValerioJurgen J. FuttererGiorgio GandagliaPrasanna SooriakumaranDerya TilkiIgor TsaurGuillaume Ploussard

A1 Journal Article in WORLD JOURNAL OF UROLOGY

Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci

Fredrick R. SchumacherAli Amin Al OlamaSonja I. BerndtSara BenllochMahbubl AhmedEdward J. SaundersTokhir DadaevDaniel LeongamornlertEzequiel AnokianClara Cieza-Borrella et al.

A1 Journal Article in NATURE GENETICS

Availability of prostate cancer exercise rehabilitation resources and practice patterns in Belgium : results of a cross-sectional study

Renée BultijnckBARBARA VAN RUYMBEKESofie EveraertHelena BaguéElke RammantSteven RimbautValerie FonteyneNicolaas LumenKarel DecaesteckerPiet Ost

A1 Journal Article in EUROPEAN JOURNAL OF CANCER CARE

Benefits of elective para-aortic radiotherapy for pN1 prostate cancer using arc therapy (intensity-modulated or volumetric modulated arc therapy) : protocol for a nonrandomized phase II trial

Cedric DraulansSteven JoniauValerie FonteyneLouke DelrueKarel DecaesteckerWouter EveraertsPiet DirixLaura Van den BerghWouter CrijnsHans Vandendriessche et al.

A2 Journal Article in JMIR RESEARCH PROTOCOLS

Cell-free DNA profiling of metastatic prostate cancer reveals microsatellite instability, structural rearrangements and clonal hematopoiesis

Markus MayrhoferBram De LaereTom WhitingtonPeter Van OyenChristophe GhyselJozef AmpePiet OstWim DemeyLucien HoekxDirk Schrijvers et al.

A1 Journal Article in GENOME MEDICINE

Challenging PD-L1 expressing cytotoxic T cells as a predictor for response to immunotherapy in melanoma

Lieve BrochezAnnabel MeiresonInes ChevoletNora SundahlPiet OstVibeke Kruse

A1 Journal Article in NATURE COMMUNICATIONS

Circulating tumor cells and survival in abiraterone- and enzalutamide-treated patients with castration-resistant prostate cancer

Bram De LaereSteffi OeyenPeter Van OyenChristophe GhyselJozef AmpePiet OstWim DemeyLucien HoekxDirk SchrijversBarbara Brouwers et al.

A1 Journal Article in PROSTATE

Clinical pathway improves implementation of evidence-based strategies for the management of androgen deprivation therapy-induced side effects in men with prostate cancer

Renée BultijnckInge Van de CaveyeElke RammantSofie EveraertNicolaas LumenKarel DecaesteckerValerie FonteyneBenedicte DeforchePiet Ost

A1 Journal Article in BJU INTERNATIONAL

Combining anticancer drugs with osteoprotective agents in prostate cancer : a contemporary update

Igor TsaurIsabel HeideggerAlexander KretschmerHendrik BorgmannCristian MirvaldGiorgio GandagliaAlberto BrigantiRoderick van den BerghDerya TilkiPiet Ost et al.

A1 Journal Article in UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

Consensus on molecular imaging and theranostics in prostate cancer

Stefano FantiSilvia MinozziGerald AntochIan BanksAlberto BrigantiIgnasi CarrioArturo ChitiNoel ClarkeMatthias EiberJohann De Bono et al.

A1 Journal Article in LANCET ONCOLOGY

Curative treatment for muscle invasive bladder cancer in elderly patients : a systematic review

Valerie FonteynePiet OstJoaquim BellmuntJean Pierre DrozPierre Mongiat-ArtusBrant InmanElena PaillaudFred SaadGuillaume Ploussard

A1 Journal Article in EUROPEAN UROLOGY

Detecting long non-coding RNA biomarkers in prostate cancer liquid biopsies : hype or hope?

Hetty HelsmoortelCeline EveraertNicolaas LumenPiet OstJo Vandesompele

A2 Journal Article in NON-CODING RNA RESEARCH

Effects of radiation on the metastatic process

Nora SundahlFréderic DuprezPiet OstWilfried De NeveMarcus Mareel

A1 Journal Article in MOLECULAR MEDICINE

Endothelial indoleamine 2,3-dioxygenase is correlated with microsatellite status in colorectal carcinoma and predicts worse prognosis

Annabel MeiresonInes ChevoletEva HulstaertLiesbeth FerdinandePiet OstKaren GeboesMarc De ManDirk Van de PutteLaurine VersetVibeke Kruse et al.

Evaluating the current place of radiotherapy as treatment option for patients with muscle invasive bladder cancer in Belgium

Valerie FonteyneElke RammantPiet OstYolande LievensBart De TroyerSylvie RotteyGert De MeerleerDaan De MaeseneerDirk De RidderKarel Decaestecker

A1 Journal Article in CLINICAL GENITOURINARY CANCER

Evaluation and preliminary radiation dosimetry of [18F]PSMA-11 for PET imaging of prostate cancer

Sarah PironKathia De ManNick Van LaekenYves D'AsselerKen KersemansPiet OstKarel DecaesteckerPieter DeseyneValerie FonteyneNicolaas Lumen et al.

Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants

Tokhir DadaevEdward J. SaundersPaul J. NewcombeEzequiel AnokianDaniel A. LeongamornlertMark N. BrookClara Cieza-BorrellaMartina MijuskovicSarah WakerellAli Amin Al Olama et al.

A1 Journal Article in NATURE COMMUNICATIONS

Focal therapy in localised prostate cancer : real-world urological perspective explored in a cross-sectional European survey

Giancarlo MarraGuillaume PloussardPiet OstPieter De VisschereAlberto BrigantiGiorgio GandagliaDerya TilkiChristian I SurcelIgor TsaurRoderick CN. Van Den Bergh et al.

A1 Journal Article in UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

Four- or 5-weeks of radiotherapy for prostate cancer : interim results of a randomized phase 3 trial

Valerie FonteyneMartijn SwimbergheElke RammantGert De MeerleerBarbara VanderstraetenFRANK VANPACHTENBEKENicolaas LumenKarel DecaesteckerPiet Ost

How can we expand active surveillance criteria in patients with low- and intermediate-risk prostate cancer without increasing the risk of misclassification? Development of a novel risk calculator

Giorgio GandagliaRoderick C. N. van den BerghDerya TilkiNicola FossatiPiet OstChristian I. SurcelPrasanna SooriakumaranIgor TsaurMassimo ValerioAlexander Kretschmer et al.

A1 Journal Article in BJU INTERNATIONAL

Impact of early salvage radiation therapy in patients with persistently elevated or rising prostate-specific antigen after radical prostatectomy

Nicola FossatiR. Jeffrey KarnesMichele ColicchiaStephen A. BoorjianAlberto BossiThomas SeisenNadia Di MuzioCesare CozzariniBarbara Noris ChiordaClaudio Fiorino et al.

A1 Journal Article in EUROPEAN UROLOGY

Management of patients with advanced prostate cancer : the report of the Advanced Prostate Cancer Consensus Conference APCCC 2017

Silke GillessenGerhardt AttardTomasz M BeerHimisha BeltranAlberto BossiRob BristowBrett CarverDaniel CastellanoByung Ha ChungNoel Clarke et al.

A1 Journal Article in EUROPEAN UROLOGY

Metastatic burden in newly diagnosed hormone-naive metastatic prostate cancer : comparing definitions of CHAARTED and LATITUDE trial

Sarah BuelensFilip PoelaertBert DhondtValerie FonteynePieter De VisscherePiet OstSofie VerbekeGeert VilleirsKathia De ManSylvie Rottey et al.

A1 Journal Article in UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

More extensive lymph node dissection at radical prostatectomy is associated with improved outcomes with salvage radiotherapy for rising prostate-specific antigen after surgery : a long-term, multi-institutional analysis

Nicola FossatiWilliam P. ParkerR. Jeffrey KarnesMichele ColicchiaAlberto BossiThomas SeisenNadia Di MuzioCesare CozzariniBarbara Noris ChiordaClaudio Fiorino et al.

A1 Journal Article in EUROPEAN UROLOGY

Multicentric prospective local treatment of metastatic prostate cancer (LOMP) trial : interim analysis of clinical outcomes and prognostic factors

Sarah BuelensFilip PoelaertBert DhondtElise De BleserCAROLINE VERBAEYSBernard RappeBart KimpeIgnace BillietHendrik PlanckeKaren Fransis et al.

Multicentric prospective local treatment of metastatic prostate cancer (LoMP) trial : interim analysis of clinical outcomes and prognostic factors

Sarah BuelensFilip PoelaertBert DhondtElise De BleserTom ClaeysCAROLINE VERBAEYSBernard RappeBart KimpeIgnace BillietHendrik Plancke et al.

Multicentrische prospectieve Lokale behandeling van Metastatische Prostaatkanker (LoMP) studie : interim analyse van de klinische uitkomsten en prognostische factoren

Sarah BuelensFilip PoelaertBert DhondtElise De BleserTom ClaeysCAROLINE VERBAEYSBernard RappeBart KimpeIgnace BillietHendrik Plancke et al.

Open surgery versus primary radiotherapy in T4b sinonasal carcinoma

Jens DebackerWouter HuvenneKatrien BonteWilfried De NevePhilippe DeronPiet OstThibaut Van ZeleHubert VermeerschFréderic Duprez

A1 Journal Article in B-ENT

Patient-reported outcomes in the search for the optimal radiotherapy schedule for prostate cancer

Elke RammantPiet OstMartijn SwimbergheFRANK VANPACHTENBEKERenée BultijnckNicolaas LumenKarel DecaesteckerValerie Fonteyne

Pembrolizumab for the treatment of bladder cancer

Nora SundahlSylvie RotteyDaan De MaeseneerPiet Ost

A1 Journal Article in EXPERT REVIEW OF ANTICANCER THERAPY

Peritumoral endothelial indoleamine 2,3-dioxygenase expression is an early independent marker of disease relapse in colorectal cancer and is influenced by DNA mismatch repair profile

Annabel MeiresonInes ChevoletEva HulstaertLiesbeth FerdinandePiet OstKaren GeboesMarc De ManDirk Van de PutteLaurine VersetVibeke Kruse et al.

A2 Journal Article in ONCOTARGET

Phase 1 dose escalation trial of ipilimumab and stereotactic body radiation therapy in metastatic melanoma

Nora SundahlKatrien De WolfVibeke KruseAnnabel MeiresonDries ReyndersEls GoetghebeurMireille Van GeleReinhart SpeeckaertBenjamin HennartLieve Brochez et al.

A1 Journal Article in INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Prognostic and therapeutic implications of circulating androgen receptor gene copy number in prostate cancer patients using droplet digital polymerase chain reaction

Sarah BuelensTom ClaeysBert DhondtFilip PoelaertMatthijs VynckNurten YigitOlivier ThasPiet OstJo VandesompeleNicolaas Lumen et al.

A1 Journal Article in CLINICAL GENITOURINARY CANCER

Prognostische significantie van metastatische symptomen bij nieuw gediagnosticeerd prostaatkanker

Elise De BleserSarah BuelensBert DhondtCAROLINE VERBAEYSBernard RappeBart KimpeIgnace BillietHendrik PlanckeKaren FrancisPatrick Willemen et al.

Prostate cancer-specific PET radiotracers : a review on the clinical utility in recurrent disease

Jaden D. EvansKrishan R. JethwaPiet OstScott WilliamsEugene D. KwonVal J. LoweBrian J. Davis

A1 Journal Article in PRACTICAL RADIATION ONCOLOGY

Reply to J.-E. Bibault et al, B. Tombal, and C. Cattrini et al

Piet OstDries ReyndersKarel DecaesteckerValerie FonteyneNicolaas LumenBieke LambertLouke DelrueGert De Meerleer

A1 Journal Article in JOURNAL OF CLINICAL ONCOLOGY

Stereotactic body radiotherapy for primary prostate cancer

Gargi KothariAndrew LoblawAlison C. TreeNicholas J. van AsDrew MoghanakiSimon S. LoPiet OstShankar Siva

A1 Journal Article in TECHNOLOGY IN CANCER RESEARCH & TREATMENT

Surveillance or metastasis-directed therapy for oligometastatic prostate cancer recurrence : a prospective, randomized, multicenter phase II trial

Piet OstDries ReyndersKarel DecaesteckerValerie FonteyneNicolaas LumenAurélie De BruyckerBieke LambertLouke DelrueRenée BultijnckTom Claeys et al.

A1 Journal Article in JOURNAL OF CLINICAL ONCOLOGY

Use of concomitant androgen deprivation therapy in patients treated with early salvage radiotherapy for biochemical recurrence after radical prostatectomy : long-term results from a large, multi-institutional series

Giorgio GandagliaNicola FossatiR. Jeffrey KarnesStephen A. BoorjianMichele ColicchiaAlberto BossiThomas SeisenCesare CozzariniNadia Di MuzioBarbara Noris Chiorda et al.

A1 Journal Article in EUROPEAN UROLOGY

Use of modern imaging methods to facilitate trials of metastasis-directed therapy for oligometastatic disease in prostate cancer : a consensus recommendation from the EORTC Imaging Group

Frederic E LecouvetDaniela E Oprea-LagerYan LiuPiet OstLuc BidautLaurence ColletteChristophe M DerooseKarolien GoffinKen HerrmannOtto S Hoekstra et al.

A1 Journal Article in LANCET ONCOLOGY

2017

A phase I/II trial of fixed-dose stereotactic body radiotherapy with sequential or concurrent pembrolizumab in metastatic urothelial carcinoma : evaluation of safety and clinical and immunologic response

Nora SundahlKatrien De WolfSylvie RotteyKarel DecaesteckerDaan De MaeseneerAnnabel MeiresonEls GoetghebeurValerie FonteyneSofie VerbekePieter De Visschere et al.

A1 Journal Article in JOURNAL OF TRANSLATIONAL MEDICINE

A phase II trial of stereotactic body radiotherapy with concurrent anti-PD1 treatment in metastatic melanoma : evaluation of clinical and immunologic response

Katrien De WolfVIBEKE KRUSENora SundahlMireille Van GeleInes ChevoletReinhart SpeeckaertLieve BrochezPiet Ost

A1 Journal Article in JOURNAL OF TRANSLATIONAL MEDICINE

Adjuvant and salvage radiotherapy after radical prostatectomy in prostate cancer patients

Giorgio GandagliaAlberto BrigantiNoel ClarkeR. Jeffrey KarnesMarkus GraefenPiet OstAnthony Laurence ZietmanMack Roach

A1 Journal Article in EUROPEAN UROLOGY

Adjuvant radiotherapy after radical cystectomy for patients with muscle invasive bladder cancer : a phase II trial

Valerie FonteynePiet DirixSara JuniusElke RammantPiet OstGert De MeerleerMartijn SwimbergheKarel Decaestecker

A1 Journal Article in BMC CANCER

Androgen receptor gene copy number and protein expression in treatment-naïve prostate cancer

Filip PoelaertCandy KumpsNicolaas LumenStéphanie VerschuereLouis LibbrechtMarleen PraetSylvie RotteyTom ClaeysPiet OstKarel Decaestecker et al.

A1 Journal Article in UROLOGIA INTERNATIONALIS

Androgen receptor gene copy number detection using droplet digital PCR and its therapeutic consequences in prostate cancer patients

Sarah BuelensTom ClaeysCandy KumpsBert DhondtFilip PoelaertNurten YigitMatthijs VynckOlivier ThasPiet OstJo Vandesompele et al.

Bijwerkingen van 'immune checkpoint' inhibitoren : waar dient een huisarts alert op te zijn?

S De KeukeleireTessa KerrePiet OstBarbara De MoerlooseKarim VermaelenLieve BrochezVibeke Kruse

A2 Journal Article in TIJDSCHRIFT VOOR GENEESKUNDE

Combined high dose radiation and pazopanib in metastatic renal cell carcinoma : a phase I dose escalation trial

Katrien De WolfSylvie RotteyKarim VermaelenKarel DecaesteckerNora SundahlLizzy De LobelEls GoetghebeurGert De MeerleerNicolaas LumenValerie Fonteyne et al.

A1 Journal Article in RADIATION ONCOLOGY

Dynamic contrast-enhanced imaging has limited added value over T2-weighted imaging and diffusion-weighted imaging when using PI-RADSv2 for diagnosis of clinically significant prostate cancer in patients with elevated PSA

Pieter De VisschereNicolaas LumenPiet OstKarel DecaesteckerEVA PATTYNGeert Villeirs

A1 Journal Article in CLINICAL RADIOLOGY

Editorial comment

Filip PoelaertPiet OstNicolaas Lumen

Editorial material

Exploring all avenues for radiotherapy in oligorecurrent prostate cancer disease limited to lymph nodes : a systematic review of the role of stereotactic body radiotherapy

Elisabetta PontiAndrea LanciaPiet OstFabio TrippaLuca TriggianiBeatrice DettiGianluca Ingrosso

A1 Journal Article in EUROPEAN UROLOGY FOCUS

Importance and outcome relevance of central pathology review in prostatectomy specimens : data from the SAKK 09/10 randomized trial on prostate cancer

Pirus GhadjarStefanie HayozVera GenitschDaniel R ZwahlenTobias HölscherPhilipp GutMatthias GuckenbergerGuido HildebrandtArndt-Christian MüllerPaul M Putora et al.

A1 Journal Article in BJU INTERNATIONAL

Metastatic burden in newly diagnosed hormone-naive metastatic prostate cancer : comparing the definitions of CHAARTED and LATITUDE trial

Sarah BuelensKarel DecaesteckerValerie FonteynePiet OstSofie VerbekeGeert VilleirsSylvie RotteyNicolaas Lumen

Pelvic lymph node dissection in prostate cancer staging : evaluation of morbidity and therapeutic effect

Andries Van HueleFilip PoelaertValerie FonteyneKarel DecaesteckerPiet OstSarah BuelensNicolaas Lumen

Prevalence and prognosis of low-volume, oligorecurrent, hormone-sensitive prostate cancer amenable to lesion ablative therapy

Aurélie De BruyckerBieke LambertTom ClaeysLouke DelrueChamberlain MbahGert De MeerleerGeert VilleirsFilip De VosKathia De ManKarel Decaestecker et al.

A1 Journal Article in BJU INTERNATIONAL

Prospective comparison of F-18 choline PET/CT scan versus axial MRI for detecting bone metastasis in biochemically relapsed prostate cancer patients

Wouter HuysseFrederic LecouvetPaolo CastellucciPiet OstVALERIE LAMBRECHTCarlos ArtigasMarie-Laurence DenisKathia De ManLouke DelrueLennart Jans et al.

A1 Journal Article in DIAGNOSTICS

Radiotherapy as metastasis-directed therapy for oligometastatic prostate cancer

Elise De BleserPhuoc T. TranPiet Ost

A1 Journal Article in CURRENT OPINION IN UROLOGY

Re: Declan G. Murphy, Christopher J. Sweeney, Bertrand Tombal. 'Gotta catch 'em all' or do we? Pokemet approach to metastatic prostate cancer. Eur Urol 2017;72:1–3

Alison C TreeShankar SivaPiet Ost

A1 Journal Article in EUROPEAN UROLOGY

Rehabilitation interventions to improve patient-reported outcomes and physical fitness in survivors of muscle invasive bladder cancer : a systematic review protocol

Elke RammantRenée BultijnckNora SundahlPiet OstNele PauwelsBenedicte DeforcheRonny PietersKarel DecaesteckerValerie Fonteyne

A2 Journal Article in BMJ OPEN

Salvage stereotactic body radiotherapy for isolated lymph node recurrent prostate cancer : single institution series of 94 consecutive patients and 124 lymph nodes

Barbara Alicja Jereczek-FossaGiuseppe FanettiCristiana FodorDelia CiardoLuigi SantoroClaudia Maria FranciaMatteo MutoAlessia SurgoDario ZeriniGiulia Marvaso et al.

A1 Journal Article in CLINICAL GENITOURINARY CANCER

The ION-Ghent guidelines for the management of immune related adverse events (irAE's)

Vibeke KruseMax SchreuerKarim VermaelenPiet OstTessa KerreBarbara De MoerlooseLieve Brochez

A2 Journal Article in BELGIAN JOURNAL OF MEDICAL ONCOLOGY

The independent oncological role for cytoreductive nephrectomy in metastatic renal cell carcinoma : prognostic features in the era of targeted therapies

Tom ClaeysNicolaas LumenCandy KumpsMarleen PraetGert De MeerleerSylvie RotteyPiet OstPieter De VisschereGeert VilleirsValerie Fonteyne et al.

A1 Journal Article in UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

The occurrence and therapeutic consequences of androgen receptor copy number gain in prostate cancer patients using Droplet Digital PCR

Sarah BuelensTom ClaeysCandy KumpsBert DhondtFilip PoelaertY NurtenMatthijs VynckOlivier ThasPiet OstJo Vandesompele et al.

Variations in target volume definition and dose to normal tissue using anatomic versus biological imaging (18F-FDG-PET) in the treatment of bone metastases : results from a 3-arm randomized phase II trial

Dieter BerwoutsKatrien De WolfWilfried De NeveAna Maria Luiza OlteanuBieke LambertBruno SpeleersIngeborg GoethalsIndira MadaniPiet Ost

A1 Journal Article in JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY

Whole pelvis radiotherapy for pathological node-positive prostate cancer

Filip PoelaertValerie FonteynePiet OstBart De TroyerKarel DecaesteckerGert De MeerleerPieter De VisschereTom ClaeysBert DhondtNicolaas Lumen

A1 Journal Article in STRAHLENTHERAPIE UND ONKOLOGIE

mRNA capture sequencing enabled liquid biopsy screening

Anneleen DecockOlivier De WeverBert DhondtCarolina FierroAn HendrixHetty HelsmoortelScott KuerstenPieter MestdaghNele NijsPiet Ost et al.

2016

Combinatie van een hoge dosis externe radiotherapie met een simultaan geïntegreerde boost op de dominante intraprostatische lesie : analyse van de genito-urnaire en rectale toxiciteit

Nora SundahlGert De MeerleerGeert VilleirsPiet OstWilfried De NeveNicolaas LumenPieter De VisschereMarc Van EijkerenValérie Fonteyne

Combining high dose external beam radiotherapy with a simultaneous integrated boost to the dominant intraprostatic lesion : analysis of genito-urinary and rectal toxicity

Nora SundahlGert De MeerleerGeert VilleirsPiet OstWilfried De NeveNicolaas LumenPieter De VisschereMarc Van EijkerenValérie Fonteyne

A1 Journal Article in RADIOTHERAPY AND ONCOLOGY

Comparison of the ACR and ESUR PIRADSv1 and v2 in a cohort of 245 patients with histopathological and/or long term follow up

Pieter De VisschereEVA PATTYNPiet OstTom ClaeysGeert Villeirs

Comparison of the Prostate Imaging Reporting and Data System (PI-RADS) version 1 and 2 in a cohort of 245 patients with histopathological reference and long-term follow-up

Pieter De VisschereEVA PATTYNPiet OstTom ClaeysNicolaas LumenGeert Villeirs

A1 Journal Article in JOURNAL OF THE BELGIAN SOCIETY OF RADIOLOGY

Individual patient data meta-analysis shows a significant association between the ATM rs1801516 SNP and toxicity after radiotherapy in 5456 breast and prostate cancer patients

Christian Nicolaj AndreassenBarry S RosensteinSarah L KernsHarry OstrerDirk De RuysscherJamie A CesarettiGillian C BarnettAlison M DunningLeila DorlingCatharine ML West et al.

A1 Journal Article in RADIOTHERAPY AND ONCOLOGY

Pattern of progression after stereotactic body radiotherapy for oligometastatic prostate cancer nodal recurrences

Piet OstBA Jereczek-FossaN Van AsT ZilliA TreeD HendersonR OrecchiaF CasamassimaA SurgoR Miralbell et al.

A1 Journal Article in CLINICAL ONCOLOGY

Practice patterns compared with evidence-based strategies for the management of androgen deprivation therapy-induced side effects in prostate cancer patients : results of a European web-based survey

Renée BultijnckCristian SurcelGuillaume PloussardAlberto BrigantiPieter De VisschereJurgen FüttererPirus GhadjarGianluca GiannariniHendrik IsbarnChristophe Massard et al.

A1 Journal Article in EUROPEAN UROLOGY FOCUS

Progression-free survival following stereotactic body radiotherapy for oligometastatic prostate cancer treatment-naive recurrence : a multi-institutional analysis

Piet OstBarbara Alicja Jereczek-FossaNicholas Van AsThomas ZilliAlexander MuacevicKenneth OlivierDaniel HendersonFranco CasamassimaRoberto OrecchiaAlessia Surgo et al.

A1 Journal Article in EUROPEAN UROLOGY

Re: Christopher JD Wallis, Refik Saskin, Richard Choo, et al. Surgery versus radiotherapy for clinically-localized prostate cancer : a systematic review and meta-analysis. Eur Urol 2016;70:21-30

Piet OstPirus Ghadjar

A1 Journal Article in EUROPEAN UROLOGY

Reply from authors re: Vincent Khoo. Is there another bite of the cherry? The case for radical local therapy for oligometastatic disease in prostate cancer. Eur Urol 2016;69:13-4 Oligometastatic prostate cancer: more than just cherry-picking?

Barbara Alicja Jereczek-FossaPiet OstGert De Meerleer

Editorial material

Role of multiparametric magnetic resonance imaging in early detection of prostate cancer

Pieter De VisschereAlberto BrigantiJurgen FüttererPirus GhadjarHendrik IsbarnChristophe MassardPiet OstPrasanna SooriakumaranCristian SurcelMassimo Valerio et al.

A2 Journal Article in INSIGHTS INTO IMAGING

The outcome for patients with pathologic node-positive prostate cancer treated with intensity modulated radiation therapy and androgen deprivation therapy: a case-matched analysis of pN1 and pN0 patients

Annelies Van HemelrykGert De MeerleerPiet OstFilip PoelaertWerner De GersemKarel DecaesteckerPieter De VisschereValérie Fonteyne

A1 Journal Article in INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Whole pelvis intensity-modulated arc therapy for lymph node metastasized prostate cancer: oncologic outcomes and prognostic factors

Filip PoelaertValérie FonteyneTom ClaeysPiet OstKarel DecaesteckerGert De MeerleerBert DhondtPieter De VisschereNicolaas Lumen

2015

Acute toxicity and early quality of life after dose intensified salvage radiotherapy for biochemically recurrent prostate cancer after prostatectomy: first results of the randomized trial SAKK 09/10

Pirus GhadjarTobias HoelscherPhilipp GutMatthias GuckenbergerGuido HildebrandtArndt-Christian MuellerLudwig PlasswilmAlexandros PapachristofilouStefanie HayozMarcin Sumila et al.

Acute toxicity and quality of life after dose-intensified salvage radiation therapy for biochemically recurrent prostate cancer after prostatectomy : first results of the randomized trial SAKK 09/10

Pirus GhadjarStefanie HayozJürg BernhardDaniel R ZwahlenTobias HölscherPhilipp GutMatthias GuckenbergerGuido HildebrandtArndt-Christian MüllerLudwig Plasswilm et al.

A1 Journal Article in JOURNAL OF CLINICAL ONCOLOGY

Biological 18[F]-FDG-PET image-guided dose painting by numbers for painful uncomplicated bone metastases: a 3-arm randomized phase II trial

Dieter BerwoutsKatrien De WolfBieke LambertRenée BultijnckWilfried De NeveLizzy De LobelLennart JansEls GoetghebeurBruno SpeleersAna Maria Luiza Olteanu et al.

A1 Journal Article in RADIOTHERAPY AND ONCOLOGY

Can we expand active surveillance criteria to include biopsy Gleason 3 + 4 prostate cancer? A multi-institutional study of 2,323 patients

Guillaume PloussardHendrik IsbarnAlberto BrigantiPrasanna SooriakumaranChristian I. SurcelLaurent SalomonMassimo FreschiCristian MirvaldHenk G. van der PoelAnna Jenkins et al.

A1 Journal Article in UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

Clinical perspectives from randomized phase 3 trials on prostate cancer : an analysis of the ClinicalTrials.gov database

Alexandros TsikkinisNikola CihoricGianluca GiannariniStefan HinzAlberto BrigantiPeter WustPiet OstGuillaume PloussardChristophe MassardCristian I. Surcel et al.

A1 Journal Article in EUROPEAN UROLOGY FOCUS

Cognitive factors influencing treatment decision-making in patients with localised prostate cancer : development of a standardised questionnaire

Julie DevosCharles Van PraetKarel DecaesteckerTom ClaeysValérie FonteyneVeerle DecalfGert De MeerleerPiet OstNicolaas Lumen

A1 Journal Article in ACTA CLINICA BELGICA

Evaluation of the effect of cytoreductive nephrectomy on the course of metastatic renal cell carcinoma: a single centre study

Tom ClaeysNicolaas LumenGilles ThuysbaertMarleen PraetGert De MeerleerSylvie RotteyPiet OstPieter De VisschereGeert VilleirsValérie Fonteyne et al.

How bad is the outcome of node positive prostate cancer patients: a matched case analysis between N+ and N0 prostate cancer patients

Valérie FonteyneAnnelies Van HemelrykNicolaas LumenPiet OstKarel DecaesteckerPieter De VisschereGert De Meerleer

Impact of changing rectal dose volume parameters over time on late rectal and urinary toxicity after high-dose intensity-modulated radiotherapy for prostate cancer : a 10-years single centre experience

Valérie FonteyneSIMIN SADEGHIPiet OstFRANK VANPACHTENBEKEPHILIPPE VUYENicolaas LumenGert De Meerleer

A1 Journal Article in ACTA ONCOLOGICA

Management of node only recurrence after primary local treatment for prostate cancer : a systematic review of the literature

Guillaume PloussardChristophe AlmerasAlberto BrigantiGianluca GiannariniChristophe HennequinPiet OstRaphaële Renard-PennaAmbroise SalinThierry LebretArnauld Villers et al.

A1 Journal Article in JOURNAL OF UROLOGY

Metastasis-directed therapy for oligometastatic prostate cancer recurrence

Karel DecaesteckerNicolaas LumenPiet Ost

Metastasis-directed therapy of regional and distant recurrences after curative treatment of prostate cancer: a systematic review of the literature

Piet OstAlberto BossiKarel DecaesteckerGert De MeerleerGianluca GiannariniR Jeffrey KarnesMack, III RoachAlberto Briganti

A1 Journal Article in EUROPEAN UROLOGY

Phase I trial of stereotactic body radiotherapy with concurrent fixed dose ipilimumab in metastatic melanoma: dose limiting toxicity and abscopal effect

Katrien De WolfPiet OstVIBEKE KRUSELieve BrochezInes Chevolet

Preferences for the management of androgen deprivation-induced osteoporosis and metabolic syndrome in prostate cancer patients: A European web-based survey

Renée BultijnckChristian SurcelGuillaume PloussardAlberto BrigantiPieter De VisschereJurgen FüttererPirus GhadjarGianluca GiannariniHendrik IsbarnChristophe Massard et al.

Preferences in management of high-risk prostate cancer among urologists in Europe: results of a web-based survey

Cristian I SurcelPrasanna SooriakumaranAlberto BrigantiPieter De VisschereJurgen J FüttererPirus GhadjarHendrik IsbarnPiet OstGuillaume PloussardRoderick CN van den Bergh et al.

A1 Journal Article in BJU INTERNATIONAL

Prognostic effect of neuroendocrine differentiation in prostate cancer : a critical review

Cristian I SurcelInge M van OortPrasanna SooriakumaranAlberto BrigantiPieter De VisschereJurgen J FüttererPirus GhadjarHenrik IsbarnPiet OstRoderick CN van den Bergh et al.

A1 Journal Article in UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

Salvage pelvic lymph node dissection in recurrent prostate cancer: surgical and early oncological outcome

Tom ClaeysCharles Van PraetNicolaas LumenPiet OstValérie FonteyneGert De MeerleerBieke LambertLouke DelruePieter De VisschereGeert Villeirs et al.

A1 Journal Article in BIOMED RESEARCH INTERNATIONAL

Systematic ultrasound-guided saturation and template biopsy of the prostate : indications and advantages of extended sampling

Henrik IsbarnAlberto BrigantiPieter De VisschereJurgen J FüttererPirus GhadjarGianluca GiannariniPiet OstGuillaume PloussardPrasanna SooriakumaranChristian I Surcel et al.

A1 Journal Article in ARCHIVOS ESPANOLES DE UROLOGIA

The oncologic role of local treatment in primary metastatic prostate cancer

Pirus GhadjarAlberto BrigantiPieter De VisschereJurgen J FüttererGianluca GiannariniHenrik IsbarnPiet OstPrasanna SooriakumaranChristian I SurcelRoderick CN Van den Bergh et al.

A1 Journal Article in WORLD JOURNAL OF UROLOGY

The potential of radiotherapy to enhance the efficacy of renal cell carcinoma therapy

Katrien De WolfKarim VermaelenGert De MeerleerBart LambrechtPiet Ost

A1 Journal Article in ONCOIMMUNOLOGY

The role of androgen receptor expression in the curative treatment of prostate cancer with radiotherapy: a pilot study

Filip PoelaertCharles Van PraetANNE-SOPHIE BEERENSGert De MeerleerValérie FonteynePiet OstNicolaas Lumen

A1 Journal Article in BIOMED RESEARCH INTERNATIONAL

What is the optimal definition of misclassification in patients with very low-risk prostate cancer eligible for active surveillance? : results from a multi-institutional series

Giorgio GandagliaGuillaume PloussardHenrik IsbarnNazareno SuardiPieter De VisschereJurgen J FüttererPirus GhadjarChristophe MassardPiet OstPrasanna Sooriakumaran et al.

A1 Journal Article in UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

2014

Comparison of fluor-18 choline PET/CT versus MRI for detecting bone metastasis in relapsed prostate cancer

Bieke LambertWouter HuysseLouke DelrueKathia De ManIngeborg GoethalsGert De MeerleerFilip De VosKarel DecaesteckerPiet Ost

Contemporary minimally-invasive extended pelvic lymph node dissection for prostate cancer before curative radiotherapy: prospective standardized analysis of complications

Charles Van PraetKarel DecaesteckerValérie FonteynePiet OstPieter De VisschereStephanie VerschuereSylvie RotteyNicolaas Lumen

A1 Journal Article in INTERNATIONAL JOURNAL OF UROLOGY

Hair-sparing whole brain radiotherapy with volumetric arc therapy in patients treated for brain metastases: dosimetric and clinical results of a phase II trial

Annemieke De PuysseleyrJoris Van de VeldeBruno SpeleersTom VercauterenAnneleen GoedgebeurTom Van HoofTom BoterbergWilfried De NeveCarlos De WagterPiet Ost

A1 Journal Article in RADIATION ONCOLOGY

Integrated models for the prediction of late genitourinary complaints after high-dose intensity modulated radiotherapy for prostate cancer: making informed decisions

Sofie De LangheGert De MeerleerKim De RuyckPiet OstValérie FonteyneWilfried De NeveHubert Thierens

A1 Journal Article in RADIOTHERAPY AND ONCOLOGY

Intensity modulated radiotherapy induces pro-inflammatory and pro-survival responses in prostate cancer patients

Houssein El SaghireCharlot VandevoordePiet OstPieter MonsieursArlette MichauxGert De MeerleerSarah BaatoutHubert Thierens

A1 Journal Article in INTERNATIONAL JOURNAL OF ONCOLOGY

Multiparametrische prostaat-MRI: klinische toepassingen

Pieter De VisschereWillem OosterlinckGert De MeerleerKarel DecaesteckerValérie FonteyneNicolaas LumenPiet OstGeert Villeirs

A2 Journal Article in TIJDSCHRIFT VOOR GENEESKUNDE

Prognostic factors influencing prostate cancer-specific survival in non-castrate patients with metastatic prostate cancer

Piet OstKarel DecaesteckerBieke LambertValérie FonteyneLouke DelrueNicolaas LumenFilip AmeyeGert De Meerleer

A1 Journal Article in PROSTATE

Radiotherapy for renal-cell carcinoma

Gert De MeerleerVincent KhooBernard EscudierSteven JoniauAlberto BossiPiet OstAlberto BrigantiValérie FonteyneMarco Van VulpenNicolaas Lumen et al.

A1 Journal Article in LANCET ONCOLOGY

Re: Stephen H. Culp, Paul F. Schellhammer, Michael B. Williams. Might men diagnosed with metastatic prostate cancer benefit from definitive treatment of the primary tumor? A SEER-based study. Eur Urol 2014;65:1058–66

Piet OstAlberto BrigantiGianluca Giannarini

A1 Journal Article in EUROPEAN UROLOGY

Rectal toxicity after intensity modulated radiotherapy for prostate cancer: which rectal dose volume constraints should we use?

Valérie FonteynePiet OstFRANK VANPACHTENBEKERoos ColmanSIMIN SADEGHIGeert VilleirsKarel DecaesteckerGert De Meerleer

A1 Journal Article in RADIOTHERAPY AND ONCOLOGY

Repeated stereotactic body radiotherapy for oligometastatic prostate cancer recurrence

Karel DecaesteckerGert De MeerleerBieke LambertLouke DelrueValérie FonteyneTom ClaeysFilip De VosWouter HuysseArne HautekietGaethan Maes et al.

A1 Journal Article in RADIATION ONCOLOGY

Salvage pelvic lymph node dissection in prostate cancer: surgical and oncological outcome

Tom ClaeysCharles Van PraetKarel DecaesteckerPiet OstValérie FonteyneGert De MeerleerPieter De VisschereGeert VilleirsNicolaas Lumen

Surveillance or metastasis-directed Therapy for OligoMetastatic Prostate cancer recurrence (STOMP): study protocol for a randomized phase II trial

Karel DecaesteckerGert De MeerleerFilip AmeyeValérie FonteyneBieke LambertSteven JoniauLouke DelrueIgnace BillietWim DuthoySarah Junius et al.

A1 Journal Article in BMC CANCER

To prospectively compare F18-choline PET/CT and axial skeleton MRI for the detection of bone metastases in patients with biochemically recurrent prostate cancer (PCa)

Piet OstWouter HuysseLouke DelrueKarel DecaesteckerGert De MeerleerFilip De VosValérie FonteyneBieke Lambert

What kind of high-grade prostate cancers do we miss with multiparametric magnetic resonance imaging?

Pieter De VisschereLeslie NaesensLouis LibbrechtCharles Van PraetNicolaas LumenPiet OstValérie FonteyneKarel DecaesteckerEVA PATTYNGeert Villeirs

2013

Acute and late toxicity after postoperative high-dose pelvic radiotherapy and androgen deprivation for node positive prostate cancer patients: a powerful tool that should be handled with care?

Charles Van PraetNicolaas LumenGert De MeerleerPiet OstKatrien VandecasteeleGeert VilleirsKarel DecaesteckerValérie Fonteyne

Acute radiation-induced nocturia in prostate cancer patients is associated with pretreatment symptoms, radical prostatectomy, and genetic markers in the TGFβ1 gene

Sofie De LangheKim De RuyckPiet OstValérie FonteyneJoke WerbrouckGert De MeerleerWilfried De NeveHubert Thierens

A1 Journal Article in INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Development of a new highly specific targeting probe for non-invasive in vivo visualization of Ncadherin expression in prostate cancer

Christian VanhoveCaroline DumolynPiet OstOlivier De WeverFilip De Vos

Developments in external beam radiotherapy for prostate cancer

Nicolaas LumenPiet OstCharles Van PraetGert De MeerleerGeert VilleirsValérie Fonteyne

A1 Journal Article in UROLOGY

Early biomarkers related to secondary primary cancer risk in radiotherapy treated prostate cancer patients: IMRT versus IMAT

Joke WerbrouckPiet OstValérie FonteyneGert De MeerleerWilfried De NeveEvelien BogaertLaurence BeelsKlaus BacherAnne VralHubert Thierens

A1 Journal Article in RADIOTHERAPY AND ONCOLOGY

Feasibility study of a Hadron Therapy Centre in Belgium

Lieven AnnemansFrancis ColardynRoger De CroockWilfried De NeveFréderic DuprezAkos GulybanKris HenauYolande LievensIndira MadaniPiet Ost et al.

High-dose intensity-modulated arc radiotherapy for lymph node metastasized prostate cancer: toxicity and early clinical outcome

Valérie FonteyneNicolaas LumenCharles Van PraetPiet OstKarel DecaesteckerGert De Meerleer

Hypofractionated frameless stereotactic intensity-modulated radiotherapy with whole brain radiotherapy for the treatment of 1-3 brain metastases

BRUNO DE POTTERGert De MeerleerWilfried De NeveTom BoterbergBruno SpeleersPiet Ost

A1 Journal Article in NEUROLOGICAL SCIENCES

Hypofractionated intensity-modulated arc therapy for lymph node metastasized prostate cancer: early late toxicity and 3-year clinical outcome

Valérie FonteyneNicolaas LumenPiet OstCharles Van PraetKatrien VandecasteeleWerner De GersemGeert VilleirsWilfried De NeveKarel DecaesteckerGert De Meerleer

A1 Journal Article in RADIOTHERAPY AND ONCOLOGY

Imaging treated prostate cancer

Pieter De VisschereHA VargasPiet OstGert De MeerleerGeert Villeirs

A1 Journal Article in ABDOMINAL IMAGING

Management of locally recurrent disease

Piet OstValérie FonteynePieter De VisschereNicolaas LumenGert De Meerleer

Bookchapter in Prostate cancer : a comprehensive perspective

Metastasis-directed therapy for oligmetastic prostate recurrence

Karel DecaesteckerGert De MeerleerLouke DelrueBieke LambertValérie FonteyneNicolaas LumenCharles Van PraetPATRICK BERKOVICGeert VilleirsPieter De Visschere et al.

Postoperative high-dose pelvic radiotherapy for N+ prostate cancer: toxicity and matched case comparison with postoperative prostate bed-only radiotherapy

Charles Van PraetPiet OstNicolaas LumenGert De MeerleerKatrien VandecasteeleGeert VilleirsKarel DecaesteckerValérie Fonteyne

A1 Journal Article in RADIOTHERAPY AND ONCOLOGY

Salvage stereotactic body radiotherapy for patients with limited prostate cancer metastases: deferring androgen deprivation therapy

PATRICK BERKOVICGert De MeerleerLouke DelrueBieke LambertValérie FonteyneNicolaas LumenKarel DecaesteckerGeert VilleirsPHILIPPE VUYEPiet Ost

A1 Journal Article in CLINICAL GENITOURINARY CANCER

The importance of the number of metastases on prostate cancer-specific survival in patients with noncastrate metastatic prostate cancer following curative treatment

Piet OstKarel DecaesteckerBieke LambertValérie FonteyneLouke DelrueNicolaas LumenGert De Meerleer

Use of EORTC target definition guidelines for dose-intensified salvage radiation therapy for recurrent prostate cancer : results of the Quality Assurance Program of the Randomized Trial SAKK 09/10

Manfred SassowskyPhilipp GutTobias HölscherGuido HildebrandtArndt-Christian MüllerYousef NajafiGötz KohlerHelmut KranzbühlerMatthias GuckenbergerDaniel R. Zwahlen et al.

A1 Journal Article in INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

2012

An immobilized antibody targeting N-cadherin facilitates spread of N-cadherin-positive tumour cells

Danielle MaesMarc BrackePiet Ost

A1 Journal Article in ANTICANCER RESEARCH

Clinical results after high-dose intensity-modulated radiotherapy for high-risk prostate cancer

Valérie FonteyneNicolaas LumenGeert VilleirsPiet OstGert De Meerleer

A2 Journal Article in ADVANCES IN UROLOGY

Detection, localisation and exclusion of high grade prostate cancer with multiparametric MRI: correlation with radical prostatectomy histopathology

Pieter De VisschereALEXANDRA DE POTTERGert De MeerleerNicolaas LumenValérie FonteynePiet OstWillem OosterlinckGeert Villeirs

Evaluation of the efficacy and safety of Salvia officinalis in controlling hot flashes in prostate cancer patients treated with androgen deprivation

Katrien VandecasteelePiet OstWillem OosterlinckValérie FonteyneWilfried De NeveGert De Meerleer

A1 Journal Article in PHYTOTHERAPY RESEARCH

High-dose adjuvant radiotherapy after radical prostatectomy with or without androgen deprivation therapy

Piet OstCesare CozzariniGert De MeerleerClaudio FiorinoBRUNO DE POTTERAlberto BrigantiEvi NaglerFrancesco MontorsiValérie FonteyneNadia De Muzio

A1 Journal Article in INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Improving positioning in high-dose radiotherapy for prostate cancer: safety and visibility of frequently used gold fiducial markers

Valérie FonteynePiet OstGeert VilleirsWillem OosterlinckALINE IMPENSWerner De GersemCarlos De WagterGert De Meerleer

A1 Journal Article in INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Limited versus extended pelvic lymph node dissection in prostate cancer patients

Charles Van PraetHeleen MaesValérie FonteyneKarel DecaesteckerGeert VilleirsPiet OstGert De MeerleerNicolaas Lumen

Population screening for prostate cancer: an overview of available studies and meta-analysis

Nicolaas LumenValérie FonteyneGert De MeerleerPiet OstGeert VilleirsAlexandre MottriePieter De VisschereBART DE TROYERWillem Oosterlinck

A1 Journal Article in INTERNATIONAL JOURNAL OF UROLOGY

Prostate MRI at 3.0T versus endorectal 1.5T: comparison of spectral and overall image quality

Pieter De VisschereGert De MeerleerKarel DecaesteckerPiet OstGeert Villeirs

Salvage radiotherapy : a plea for dose-escalation with intensity-modulated radiotherapy

Piet OstCesare CozzariniAlberto BossiGert De Meerleer

A1 Journal Article in EUROPEAN JOURNAL OF CANCER

Salvage stereotactic body radiotherapy for patients with limited prostate cancer metastases: deferring androgen deprivation therapy

PATRICK BERKOVICGert De MeerleerLouke DelrueBieke LambertValérie FonteyneNicolaas LumenKarel DecaesteckerGeert VilleirsPHILIPPE VUYEPiet Ost

Screening and early diagnosis of prostate cancer: an update

Nicolaas LumenValérie FonteyneGert De MeerleerPieter De VisscherePiet OstWillem OosterlinckGeert Villeirs

A1 Journal Article in ACTA CLINICA BELGICA

Surgical outcome of robot-assisted radical prostatectomy after a training program in a high-volume robotic centre

Charles Van PraetNicolaas LumenBART DE TROYERValérie FonteyneKarel DecaesteckerGert De MeerleerWillem OosterlinckPiet OstAlexandre Mottrie

Whole abdominopelvic radiotherapy (WAPRT) using intensity modulated arc therapy (IMAT) as palliation for chemotherapy-resistant ovarian cancer

Katrien VandecasteeleAmin MakarPhilippe TummersHannelore DenysRudy Van den BroeckeLouke DelruePieter De VisscherePiet OstGert De Meerleer

2011

A comparison of the acute toxicity profile between two-dimensional and three-dimensional image-guided radiotherapy for postoperative prostate cancer

Piet OstWerner De GersemBRUNO DE POTTERValérie FonteyneWilfried De NeveGert De Meerleer

A1 Journal Article in CLINICAL ONCOLOGY

A matched control analysis of adjuvant and salvage high-dose postoperative intensity-modulated radiotherapy for prostate cancer

Piet OstBART DE TROYERValérie FonteyneWillem OosterlinckGert De Meerleer

A1 Journal Article in INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Analysis of prostate bed motion using daily cone-beam computed tomography during postprostatectomy radiotherapy

Piet OstGert De MeerleerWerner De Gersem

A1 Journal Article in INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Delineation of the postprostatectomy prostate bed using computed tomography: interobserver variability following the EORTC delineation guidelines

Piet OstGert De MeerleerTom VercauterenWerner De GersemLiv VeldemanKatrien VandecasteeleValérie FonteyneGeert Villeirs

A1 Journal Article in INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

High-dose salvage intensity-modulated radiotherapy with or without androgen deprivation after radical prostatectomy for resing or persisting prostate specific antigen : 5-year results

Piet OstNicolaas LumenAn-Sofie GoessaertValérie FonteyneBART DE TROYERFilip JacobsGert De Meerleer

A1 Journal Article in EUROPEAN UROLOGY

Intensity-modulated radiotherapy: the gold standard for postprostatectomy irradiation?

Alberto BossiGert De MeerleerPiet Ost

Editorial material

Volumetric arc therapy and intensity-modulated radiotherapy for primary prostate radiotherapy with simultaneous integrated boost to intraprostatic lesion with 6 and 18 MV: a planning comparison study

Piet OstBruno SpeleersGert De MeerleerWilfried De NeveValérie FonteyneGeert VilleirsWerner De Gersem

A1 Journal Article in INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Whole abdominopelvic radiotherapy using intensity-modulated arc therapy in the palliative treatment of chemotherapy-resistant ovarian cancer with bulky peritoneal disease: a single-institution experience

Gert De MeerleerKatrien VandecasteelePiet OstLouke DelrueHannelore DenysAmin MakarBruno SpeleersSimon Van BelleRudy Van den BroeckeValérie Fonteyne et al.

A1 Journal Article in INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

2010

Re: Michael L. Eisenberg, Benjamin J. Davies, Matthew R. Cooperbert, et al. Prognostic implications of an undetectable ultrasensitive prostate-specific antigen level after radical prostatectomy. Eur Urol 2010;57:622-30

Piet OstAlberto BossiGert De Meerleer

A2 Journal Article in EUROPEAN UROLOGY

2009

Adjuvant High-Dose Intensity-Modulated Radiotherapy after Radical Prostatectomy for Prostate Cancer: Clinical Results in 104 Patients

Piet OstValérie FonteyneGeert VilleirsNicolaas LumenWillem OosterlinckGert De Meerleer

A1 Journal Article in EUROPEAN UROLOGY

Volumetric modulated arc therapy for delivery of prostate radiotherapy: in regard to Palma et al. (Int J Radiat Oncol Biol Phys 2008;70:996-1001)

Piet OstValérie FonteyneWilfried De NeveWerner De GersemCarlos De WagterKatrien VandecasteeleFréderic DuprezGert De Meerleer

A1 Journal Article in INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

2008

F-18 fluorodeoxyglucose PET/CT scanning in the diagnostic work-up of a primary pericardial mesothelioma - A case report

Piet OstSylvie RotteyPeter SmeetsTom BoterbergBarbara StragierIngeborg Goethals

A1 Journal Article in Journal of Thoracic Imaging

Salvage intensity-modulated radiotherapy for rising PSA after radical prostatectomy

Gert De MeerleerValérie FonteyneSABINE MEERSSCHOUTCaroline Van den BroeckeGeert VilleirsNicolaas LumenPiet OstKatrien VandecasteeleWilfried De Neve

A1 Journal Article in RADIOTHERAPY AND ONCOLOGY

2005

Postoperative intensity-modulated radiotherapy in sinonasal carcinoma - Clinical results in 39 patients

WIM DUTHOYTom BoterbergF CLAUSPiet OstLuc VakaetS BRALFréderic DuprezM VAN LANDUYTHubert VermeerschWilfried De Neve

A1 Journal Article in CANCER

2002

Postoperative radiotherapy for adenocarcinoma of the ethmoid sinuses: Treatment results for 47 patients

F CLAUSTom BoterbergPiet OstJEROEN HUYSHubert VermeerschSABINE BRAEMSKatrien BonteMieke MOERMANChristoph VERHOYEWilfried De Neve

A1 Journal Article in INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Short term toxicity profile for 32 sinonasal cancer patients treated with IMRT. Can we avoid dry eye syndrome?

Filip ClausTom BoterbergPiet OstWilfried De Neve

A1 Journal Article in Radiotherapy and Oncology